rfhg_91100.1

Basic information about the TSS

---

TSS ID: rfhg_91100.1 Species: human Chr: chr7		Start: 5528317 End: 5528352 Strand: -
Source datasets	PRJNA615891|PRJNA4843412|DRA013844
Protocol	TIF-seq2|NETCAGE|CAGE
TSS cluster detected*	3

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3941268,EH38E2531596)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: V00478:0 GeneID: 60 HGNC/MGI_ID: HGNC:132 UniProt_ID: Nearer transcript ids and distances: M28424:18 HQ154074:-31 DQ407611:-105 EF036500:-114 ENST00000464611.1:219 view more...

Gene_name: actin beta Gene_symbol: ACTB Gene_synonyms: Gene_source: HGNC:132

TATA-Box annotation

---

Distance to TSS:	2267
Nearest PromoterID:	NM_001101
Entrez ID:	60
Nearest Unigene:	Hs.520640
Nearest Refseq:	NM_001101
Nearest Ensembl:	ENSG00000075624
Gene Name:	actin beta
Gene Alias:	BRWS1|PS1TP5BP1
Gene Type:	protein-coding
CpG%:	0.057143
GC%:	0.583333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ACTB p2@ACTB p4@ACTB p5@ACTB p6@ACTB p8@ACTB p9@ACTB p10@ACTB
Sample		p1@ACTB	p2@ACTB	p4@ACTB	p5@ACTB	p6@ACTB	p8@ACTB	p9@ACTB	p10@ACTB
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	1951.93	21.43	2.92	2.73	4.09	5.84	2.14	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	2001.33	22.66	3.24	3.44	2.23	8.30	2.02	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	2047.29	21.41	4.05	3.28	3.67	7.72	1.35	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1776.38	22.45	2.70	2.70	1.66	4.99	2.49	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	1852.60	24.97	4.27	2.47	2.02	4.72	0.90	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	1844.88	21.13	4.07	4.26	1.74	4.26	1.55	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	2081.88	23.97	3.92	3.70	3.05	6.54	0.87	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	1789.28	17.20	3.15	1.70	4.12	4.60	1.70	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	1921.74	19.02	1.92	1.50	2.78	4.92	1.07	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	890.89	16.81	3.48	1.16	0.00	2.32	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	844.45	16.98	1.62	2.02	0.40	2.83	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	826.52	16.67	1.63	2.03	0.00	0.41	1.22	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	2749.30	13.54	9.35	6.77	7.41	26.44	5.00	4.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	2624.66	15.19	9.32	5.86	7.82	30.37	4.81	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	2458.12	10.10	7.90	4.83	6.59	22.83	4.83	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	2743.76	20.37	17.35	7.04	8.05	28.17	7.29	3.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	2642.73	12.45	7.43	4.80	6.55	25.77	4.37	2.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	2705.11	20.25	17.72	11.39	5.06	32.48	4.64	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	2475.44	15.99	12.26	3.73	4.27	11.20	4.27	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	2376.98	13.09	6.77	4.51	11.58	34.75	5.12	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	2607.82	13.77	12.16	6.15	7.35	25.39	4.95	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	2418.80	10.70	8.11	6.56	6.21	30.04	4.32	3.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	2472.17	12.54	8.14	6.72	6.46	19.78	3.62	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	2481.28	12.38	16.26	5.34	5.58	32.27	5.10	3.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	2453.48	11.61	8.77	5.93	5.68	28.89	5.68	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	2410.87	8.55	7.60	7.28	5.06	33.23	6.96	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	2442.90	13.19	4.95	6.59	6.04	20.88	4.40	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	2878.31	8.25	6.60	5.42	12.26	19.33	3.54	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	2403.15	10.18	6.14	5.49	7.43	27.62	4.68	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	2417.70	8.32	11.76	4.89	9.95	30.04	4.89	3.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	2497.89	14.24	13.19	6.70	4.19	25.54	3.77	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	2454.97	11.14	7.23	5.08	7.42	32.43	8.60	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	2775.03	15.62	7.17	8.65	4.22	39.46	4.01	3.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	2754.33	11.22	7.75	8.41	8.58	21.77	5.11	2.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	2411.42	13.65	8.79	5.61	7.29	43.76	6.36	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	2564.30	14.56	10.73	3.64	7.66	24.14	5.94	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	2468.91	11.85	8.38	6.95	10.63	38.83	5.52	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	2564.32	9.07	10.88	4.23	11.28	27.40	6.65	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	2570.57	9.45	8.91	4.86	8.64	25.39	6.75	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	2254.18	9.84	9.36	4.80	6.48	22.57	5.76	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	2521.75	10.82	7.76	4.00	5.41	27.53	5.65	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	2532.77	10.54	6.59	4.54	4.98	26.06	6.73	2.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	2308.23	10.97	7.17	4.01	8.86	37.54	7.59	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	2568.04	13.64	11.01	4.02	6.99	34.62	7.52	3.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	2362.09	10.24	9.44	5.42	10.04	26.30	8.43	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	2439.06	16.52	13.96	8.14	8.38	53.97	8.61	5.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	2650.48	10.08	6.72	3.60	6.48	23.03	8.64	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	2359.36	11.03	8.94	3.87	9.24	32.49	9.84	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	2526.35	11.97	8.86	5.03	11.49	32.32	6.46	2.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	2260.16	11.53	5.46	3.24	11.32	29.32	7.89	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	2288.10	13.32	13.94	8.61	8.20	25.00	7.38	2.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	2492.59	15.79	14.90	8.23	8.01	35.58	5.56	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1385.23	13.99	27.98	13.99	13.99	55.97	41.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	2801.96	14.55	15.26	7.10	6.39	23.42	4.61	4.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	2766.40	15.24	13.26	10.27	8.62	18.56	5.30	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1767.64	10.91	10.91	11.75	6.71	88.93	6.71	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	2025.26	14.24	9.18	5.51	5.05	43.63	5.97	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	2926.37	14.26	19.45	5.19	10.05	21.39	11.67	4.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	2978.85	17.02	11.56	7.39	5.78	15.42	8.99	3.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	2342.70	13.83	11.63	10.06	9.12	76.38	9.12	4.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	3463.22	17.63	13.40	5.64	10.58	22.56	3.53	7.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	3486.98	17.95	20.75	6.73	7.85	20.75	7.29	3.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	2461.67	26.27	23.09	45.38	20.70	232.47	12.74	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	2363.42	18.01	10.19	9.17	7.47	77.13	6.80	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	3594.60	28.92	30.87	11.70	13.00	28.59	13.65	9.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	3921.46	19.88	24.49	8.87	7.10	28.40	15.26	5.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1761.87	16.16	32.33	32.33	16.16	129.31	80.82	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1824.32	0.00	15.79	7.90	15.79	181.64	63.18	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	4734.27	38.03	48.26	14.63	11.70	40.46	9.75	8.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	4725.66	27.77	47.11	16.36	16.36	39.17	11.41	12.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	4555.10	13.60	19.70	8.91	10.32	16.89	6.10	7.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	2407.74	10.60	16.56	7.29	7.29	42.72	7.29	6.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	3157.76	20.73	33.41	10.21	15.78	25.06	13.61	10.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	3176.99	17.43	21.40	8.87	10.09	19.26	6.42	7.03
Adipocyte - breast, donor1	11376-118A8	9647.17	50.05	19.64	14.41	11.56	18.53	11.72	5.86
Adipocyte - breast, donor2	11327-117E4	5962.90	28.24	13.80	11.07	19.73	11.71	9.95	11.71
Adipocyte - omental, donor1	11473-119C6	9198.04	53.05	19.08	14.38	18.70	14.00	10.81	8.02
Adipocyte - omental, donor2	11474-119C7	8053.49	35.13	23.92	16.44	38.12	32.89	22.42	6.73
Adipocyte - omental, donor3	11475-119C8	5182.88	23.78	15.74	9.04	30.81	12.73	26.12	9.04
Adipocyte - perirenal, donor1	11476-119C9	7356.03	26.16	29.99	12.12	40.19	19.78	25.52	10.21
Adipocyte - subcutaneous, donor1	11259-116F8	4250.69	25.29	7.70	5.50	23.09	16.49	8.80	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	2723.30	16.71	3.16	4.52	6.32	2.71	3.61	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	1923.00	10.77	4.69	4.52	6.08	4.87	1.74	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	3820.50	11.93	9.19	10.17	9.78	4.30	3.91	2.15
Adipocyte differentiation, day04, donor2	13022-139D7	2344.47	9.27	8.49	4.89	2.06	1.54	0.77	3.09
Adipocyte differentiation, day04, donor3	13025-139E1	3516.44	12.54	7.53	8.64	5.58	2.79	1.39	4.18
Adipocyte differentiation, day04, donor4	13028-139E4	1892.16	7.64	7.05	1.18	2.35	1.18	1.76	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	1398.81	9.25	3.22	2.90	5.15	1.61	0.72	1.37
Adipocyte differentiation, day08, donor2	13023-139D8	1800.33	11.30	6.13	4.52	2.26	3.23	1.61	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	1881.09	11.20	6.93	3.20	5.33	2.67	2.13	2.67
Adipocyte differentiation, day08, donor4	13029-139E5	1385.53	6.68	6.12	4.45	1.11	1.11	1.67	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	1676.88	4.16	4.16	2.91	3.33	2.50	2.91	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	1800.10	8.79	7.28	3.01	1.76	2.26	1.26	1.51
Adipocyte differentiation, day12, donor3	13027-139E3	1730.47	9.16	5.56	2.62	3.27	0.98	0.98	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	1033.98	7.31	5.18	3.96	1.22	2.74	1.22	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	11914.42	30.50	15.69	15.47	5.97	6.41	2.43	9.72
Alveolar Epithelial Cells, donor2	11590-120G6	17521.38	33.35	41.60	14.70	34.07	30.12	23.67	12.91
Alveolar Epithelial Cells, donor3	11671-122G6	6543.56	15.57	10.78	8.39	7.19	8.39	5.99	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	7099.08	23.39	17.09	13.67	3.24	6.12	1.62	5.76
Amniotic Epithelial Cells, donor2	11613-122A2	2895.15	20.08	6.69	1.67	0.00	3.35	8.37	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	6939.80	26.71	14.18	7.40	15.20	4.31	2.47	5.14
Anulus Pulposus Cell, donor1	11248-116E6	3473.85	14.65	6.41	6.18	4.00	4.92	1.14	2.63
Anulus Pulposus Cell, donor2	11463-119B5	2359.19	12.98	6.12	5.14	5.88	6.37	1.71	1.71
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	5376.27	23.81	19.77	19.32	11.23	17.52	8.09	5.84
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6244.68	33.43	19.54	16.50	11.29	8.25	6.95	6.08
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	5155.86	55.65	17.12	27.82	0.00	36.38	4.28	8.56
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	5636.47	26.31	14.65	20.33	14.05	11.66	6.88	4.78
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5494.91	36.67	24.03	17.71	16.44	16.44	6.32	5.06
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	4774.95	33.66	17.82	24.42	6.60	17.16	7.26	6.60
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	5376.86	25.99	13.32	14.62	13.65	10.07	5.52	4.87
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6025.77	24.76	15.53	13.11	7.28	11.17	7.28	3.40
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5049.16	40.38	27.91	22.57	5.34	18.41	9.50	11.28
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	5428.85	32.39	19.59	16.57	12.43	14.31	7.91	6.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5748.06	29.75	21.04	18.14	6.53	8.71	9.43	3.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	4961.19	26.33	25.08	20.06	2.51	17.55	10.03	7.52
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	5167.78	28.66	9.88	2.97	3.62	2.31	2.64	2.64
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5572.48	24.57	17.74	15.01	5.46	6.82	2.73	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4259.40	29.56	9.65	13.27	2.11	7.54	3.47	4.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	5874.37	37.51	12.86	13.93	12.32	12.32	6.43	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	5224.45	33.63	26.64	20.59	12.28	21.73	9.82	9.26
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5565.70	35.82	20.58	14.43	7.75	12.83	5.35	5.61
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5523.01	26.34	14.63	26.34	4.88	11.71	11.71	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5093.88	32.34	22.06	19.57	12.94	14.10	5.64	6.14
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	4975.80	31.22	40.82	28.82	3.60	14.41	6.00	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3380.85	21.24	14.16	7.08	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	5147.61	24.01	18.18	19.38	10.81	11.32	6.52	7.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4597.68	20.97	20.97	12.58	4.19	8.39	4.19	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5900.34	33.98	24.27	12.62	10.68	12.14	8.25	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	5765.76	28.46	15.18	20.49	13.66	9.87	4.55	7.21
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	5000.51	29.07	26.65	19.38	3.63	18.17	7.27	15.75
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5773.88	30.78	18.81	22.23	8.55	17.67	4.56	5.70
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5050.86	33.35	16.03	16.03	11.12	8.76	3.63	5.99
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4773.37	32.78	14.71	19.87	8.00	9.81	6.45	6.19
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6073.88	31.44	13.61	16.89	8.45	8.91	7.98	4.69
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5096.24	30.23	20.58	20.26	10.93	11.25	8.36	7.72
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4653.13	29.25	21.40	14.98	5.71	9.27	8.56	7.13
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5397.35	36.85	14.62	11.70	5.26	8.19	7.02	4.68
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	5136.30	31.31	19.27	15.35	9.33	10.24	6.62	4.82
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4871.95	36.83	24.95	21.38	2.38	22.57	7.13	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5916.08	34.58	18.82	23.90	13.73	17.80	8.65	6.61
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	5141.90	27.00	18.34	23.18	9.93	20.63	10.95	7.39
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	4730.95	36.22	19.06	21.60	3.18	10.17	6.35	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5918.05	30.21	12.51	17.26	6.90	12.08	6.47	5.61
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5030.08	30.06	24.98	19.90	14.61	16.30	6.14	9.31
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4579.97	27.55	17.11	18.27	3.77	12.18	6.96	6.67
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6254.15	30.23	14.17	17.95	15.12	7.56	5.67	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	5154.91	28.65	25.09	24.75	9.15	13.39	6.78	6.10
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	5163.18	39.38	44.01	23.16	2.32	9.27	6.95	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4909.62	23.24	6.34	10.56	6.34	4.23	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5137.53	32.81	16.72	14.58	12.86	9.86	4.93	7.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5111.13	40.31	31.89	21.06	4.81	6.62	9.02	7.82
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5511.79	43.74	21.87	19.68	9.48	17.50	10.93	6.56
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5447.49	34.48	14.71	18.85	10.34	10.34	5.52	8.51
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5174.56	35.70	53.56	12.75	5.10	17.85	17.85	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4196.85	30.76	19.07	10.93	1.02	7.88	3.81	4.32
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5444.02	33.86	18.79	16.72	12.18	7.64	4.95	7.43
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4898.76	34.88	20.50	14.38	6.73	9.18	7.04	6.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	5913.49	30.59	21.51	19.60	13.38	14.34	5.26	5.74
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	5351.92	29.93	23.06	19.07	10.87	10.42	5.54	5.77
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4839.83	41.20	33.57	22.89	4.58	22.89	12.21	9.15
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	5027.09	29.36	13.85	19.94	6.65	8.31	3.88	3.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	4812.64	30.98	18.54	14.83	12.18	8.21	3.18	6.36
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4555.09	31.98	14.90	15.26	5.45	11.99	9.45	8.72
Astrocyte - cerebellum, donor1	11500-119F6	11002.38	50.48	18.42	9.83	4.30	5.65	6.02	6.63
Astrocyte - cerebellum, donor2	11580-120F5	9708.02	38.17	19.34	7.87	27.73	15.92	10.27	9.76
Astrocyte - cerebellum, donor3	11661-122F5	6964.24	29.57	15.73	4.40	10.07	4.40	2.73	3.78
Astrocyte - cerebral cortex, donor1	11235-116D2	6681.68	19.52	16.38	12.90	7.32	7.32	6.27	7.32
Astrocyte - cerebral cortex, donor2	11316-117D2	7200.22	32.84	15.69	9.06	13.59	6.79	3.40	7.77
Astrocyte - cerebral cortex, donor3	11392-118C6	8579.85	41.76	20.14	13.28	13.13	7.91	3.73	9.10
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	11659.50	36.36	13.07	11.93	24.54	17.32	9.98	11.70
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	13535.94	38.09	14.66	16.41	24.30	15.03	10.40	6.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	11140.68	32.77	14.91	12.40	18.78	11.04	10.13	8.19
Basophils, donor1	12241-129G9	7748.17	19.61	14.12	15.17	1.57	8.11	0.52	6.02
Basophils, donor2	12242-129H1	5309.46	10.46	14.43	13.35	1.80	4.69	1.44	4.33
Basophils, donor3	12243-129H2	6902.25	13.67	13.96	12.64	7.79	6.91	2.50	5.00
Bronchial Epithelial Cell, donor1	11511-119G8	4993.37	9.49	8.41	8.41	2.80	3.45	1.29	3.23
Bronchial Epithelial Cell, donor2	11591-120G7	11148.02	21.94	22.86	8.23	35.20	15.54	14.17	5.49
Bronchial Epithelial Cell, donor3	11672-122G7	1800.57	28.69	43.04	7.17	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	8859.94	23.85	25.11	10.67	22.60	6.28	6.28	8.79
Bronchial Epithelial Cell, donor5	11457-119A8	13293.03	29.74	24.95	11.02	45.33	5.41	4.99	10.19
Bronchial Epithelial Cell, donor6	11461-119B3	4624.69	21.19	17.73	4.38	25.10	2.99	2.07	4.84
Bronchial Epithelial Cell, donor7	11769-123I5	2796.35	8.46	7.38	5.22	5.76	5.04	3.42	3.06
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4385.62	10.72	7.63	7.11	2.78	1.96	1.55	4.12
Burkitt's lymphoma cell line:RAJI	10476-106I8	3724.36	15.37	10.01	16.30	1.86	3.26	1.63	3.49
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	4045.15	4.48	3.52	5.44	0.64	4.16	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	4033.36	20.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	6714.77	12.96	22.54	18.03	2.82	6.76	6.76	9.02
CD14+ Monocytes, donor2	11305-117B9	5863.50	13.18	10.02	7.05	10.02	3.90	4.08	5.38
CD14+ Monocytes, donor3	11381-118B4	5266.68	14.93	18.66	16.68	9.66	8.34	9.22	4.61
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	3503.24	8.77	11.32	16.42	13.02	3.40	4.25	4.53
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	3262.32	6.44	7.20	6.82	4.93	3.79	3.03	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	3506.02	5.59	8.55	11.83	15.45	3.29	3.62	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	4619.06	14.02	10.12	8.96	12.86	8.38	5.93	6.36
CD14+ monocytes - mock treated, donor2	11873-125C1	3223.82	6.03	6.64	8.75	6.03	2.41	2.41	3.62
CD14+ monocytes - mock treated, donor3	11883-125D2	3992.36	8.77	11.13	9.48	5.45	4.74	3.32	3.55
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4547.36	13.73	13.73	6.70	7.03	3.52	4.18	7.20
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3540.13	6.90	9.94	11.04	5.24	5.80	3.59	2.76
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4506.85	8.68	13.14	9.42	6.45	4.96	3.72	5.21
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4818.85	12.34	17.82	10.57	7.64	5.48	5.29	7.64
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3974.40	9.44	12.29	6.23	8.19	5.34	4.45	2.49
CD14+ monocytes - treated with BCG, donor3	11880-125C8	4223.77	10.23	6.53	7.62	5.66	3.05	1.31	2.39
CD14+ monocytes - treated with Candida, donor1	11868-125B5	4400.41	8.19	11.47	9.60	6.09	7.73	2.11	5.62
CD14+ monocytes - treated with Candida, donor2	11878-125C6	4141.85	14.26	8.98	12.14	4.75	7.39	1.06	5.28
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3708.58	3.33	9.98	7.77	3.33	7.77	0.00	3.33
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4277.71	10.56	12.64	5.80	8.18	7.73	5.50	6.69
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3292.74	6.98	6.39	7.98	5.59	4.99	2.39	3.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3273.93	8.95	8.33	10.20	4.58	5.20	3.54	2.91
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5966.02	12.58	15.56	11.67	12.35	13.04	8.92	8.01
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3834.38	7.01	4.75	8.14	1.36	4.75	0.68	2.04
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	4036.39	6.98	7.42	13.09	6.11	7.86	3.49	3.49
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	3543.13	9.15	11.03	2.42	5.65	3.50	5.11	2.42
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3679.54	7.85	8.03	6.28	7.85	3.49	2.79	5.93
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	3498.70	9.26	11.78	6.73	3.37	3.37	2.10	2.95
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5182.48	13.41	11.76	8.27	8.45	4.59	5.14	5.51
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4092.97	11.27	9.51	7.05	4.93	2.11	3.87	4.58
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	4364.88	8.77	10.53	15.79	5.70	4.39	2.19	3.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4426.48	9.76	11.51	13.60	5.93	5.58	4.88	4.36
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3745.02	8.92	14.50	18.58	5.95	6.69	2.97	3.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	4295.47	7.33	7.98	8.41	4.96	4.74	1.94	2.37
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4210.35	7.37	10.24	4.50	2.05	2.87	2.87	2.46
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3316.35	3.94	7.88	7.42	1.16	2.55	0.70	2.32
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3084.33	8.82	5.57	11.37	3.02	4.41	2.78	3.71
CD14+CD16+ Monocytes, donor1	11789-124B7	8270.64	22.67	15.48	10.24	3.92	6.76	2.18	3.49
CD14+CD16+ Monocytes, donor2	11801-124D1	9166.56	19.87	20.10	12.01	7.16	10.86	4.62	5.77
CD14+CD16+ Monocytes, donor3	11912-125G4	7820.91	14.73	12.13	7.58	2.82	4.77	1.73	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	9480.51	16.97	13.39	10.12	6.85	8.88	3.58	4.67
CD14+CD16- Monocytes, donor2	11799-124C8	7850.26	11.18	13.62	9.78	6.99	6.99	3.14	3.84
CD14+CD16- Monocytes, donor3	11910-125G2	8129.90	12.71	16.28	11.59	4.24	4.24	2.45	4.68
CD14-CD16+ Monocytes, donor1	11790-124B8	8748.66	23.99	18.12	5.36	2.04	11.48	2.04	3.83
CD14-CD16+ Monocytes, donor2	11800-124C9	9241.49	26.13	19.98	10.10	9.00	9.88	5.49	2.85
CD14-CD16+ Monocytes, donor3	11911-125G3	8926.73	22.74	15.16	13.69	4.42	9.26	2.95	3.79
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4001.62	10.16	2.03	0.00	0.00	6.10	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4171.60	12.20	4.75	3.39	2.03	2.71	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	4027.44	8.28	9.32	4.14	1.04	3.11	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	3410.91	6.93	9.06	8.53	1.07	6.40	1.07	3.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	4951.66	14.47	11.79	6.43	3.75	3.22	2.68	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	3706.94	6.32	5.62	2.11	0.70	2.11	0.00	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4532.79	6.27	12.55	6.27	2.35	7.06	0.00	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	4168.42	5.27	5.27	9.23	0.00	3.95	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	3520.20	9.86	9.04	6.58	5.75	5.75	3.29	2.47
CD19+ B Cells, donor2	11624-122B4	3438.53	5.08	7.98	7.25	4.35	1.45	4.35	1.45
CD19+ B Cells, donor3	11705-123B4	3113.26	7.57	6.56	6.06	5.05	2.52	2.02	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	3506.41	8.49	4.04	4.04	2.02	4.44	1.62	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2963.02	6.79	3.99	6.39	1.20	3.60	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	1912.71	2.01	4.02	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	2166.89	2.81	3.37	1.12	0.56	1.12	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	4127.67	10.90	9.02	7.52	4.51	4.88	2.63	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	4479.68	10.37	7.44	4.74	2.48	2.71	0.45	0.45
CD4+ T Cells, donor1	11225-116C1	3564.50	12.14	6.78	10.71	2.50	3.93	1.43	3.21
CD4+ T Cells, donor2	11306-117C1	3840.74	18.98	13.47	4.29	6.12	6.74	3.06	2.45
CD4+ T Cells, donor3	11382-118B5	4622.78	21.04	16.47	11.59	6.10	9.45	3.05	6.40
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	7778.59	19.40	14.55	5.10	8.42	10.46	4.59	4.85
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	8169.05	30.32	19.76	11.68	5.39	10.56	4.49	5.39
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	7679.22	22.71	18.40	11.50	4.60	6.61	4.02	7.19
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	4195.23	12.33	7.11	2.84	4.27	2.37	1.90	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	4241.32	9.13	4.21	2.11	1.40	4.21	1.40	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	4430.12	9.89	0.00	3.30	0.00	0.00	9.89	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	7566.25	47.69	16.76	9.83	14.16	8.53	2.60	6.21
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	9507.02	48.47	27.11	26.61	14.74	12.71	14.07	12.37
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	8242.61	43.69	24.99	21.76	12.25	9.67	8.38	9.67
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	5892.44	30.48	13.00	4.93	3.59	4.93	2.69	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	6362.36	25.16	13.98	6.64	5.94	5.24	1.75	2.80
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	5546.40	25.96	9.68	11.44	3.08	3.08	2.20	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	8216.10	37.95	16.02	12.23	6.75	4.22	2.53	6.75
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	9654.02	48.20	46.75	30.33	5.40	12.67	14.34	8.73
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	8928.56	40.10	24.39	23.39	3.68	9.69	13.37	6.35
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	4185.61	12.24	6.25	2.72	4.08	5.44	1.63	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3673.40	12.33	6.97	4.29	1.61	1.07	1.07	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	4246.36	10.76	7.17	5.38	7.17	5.38	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	10895.58	70.28	27.81	15.58	8.90	10.01	4.64	9.27
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	9694.93	47.44	14.51	12.35	9.96	11.91	10.40	5.63
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	11521.36	67.88	18.70	13.45	11.35	11.14	9.88	5.25
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	5227.45	19.72	4.55	2.53	3.03	4.04	0.51	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	5052.14	13.86	9.53	3.47	2.17	4.33	1.73	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	5339.61	19.18	16.13	9.59	5.67	5.23	0.00	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	6697.56	24.74	12.37	5.44	3.46	4.95	3.46	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	5508.65	15.69	8.31	1.85	3.69	4.62	2.77	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	6053.68	30.71	8.37	1.40	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	6979.16	13.57	6.92	3.05	8.86	3.32	1.94	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	7755.09	17.18	10.31	4.17	7.85	4.17	2.94	3.44
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	5334.58	24.64	18.48	3.08	1.54	4.62	1.54	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	7294.50	23.64	11.82	5.73	5.37	5.73	2.15	3.58
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	7014.98	16.62	6.92	0.00	4.15	2.77	2.77	1.38
CD8+ T Cells, donor1	11226-116C2	4259.42	27.17	9.17	15.39	3.27	6.55	4.26	5.24
CD8+ T Cells, donor2	11307-117C2	4006.23	22.90	8.63	7.13	4.13	9.39	6.01	4.13
CD8+ T Cells, donor3	11383-118B6	3956.25	18.94	12.88	10.86	8.08	4.80	5.05	3.79
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	8880.44	68.59	18.35	4.82	7.57	25.00	7.34	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	8647.50	69.74	23.96	7.91	7.19	30.19	6.23	2.64
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	8675.04	79.89	28.45	11.49	10.12	31.19	5.75	4.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	11014.75	76.85	27.92	11.11	15.01	30.02	4.20	3.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	9125.10	62.64	19.92	10.32	5.28	8.88	3.84	1.92
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8503.54	66.62	20.92	7.28	6.14	14.55	5.23	3.64
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8260.49	62.58	15.21	7.39	7.82	17.17	3.91	1.74
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	8396.47	76.07	30.01	7.63	8.69	20.27	3.42	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	8377.60	69.65	15.71	4.46	6.57	21.58	6.57	2.81
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6673.60	64.30	27.17	9.36	5.13	23.55	5.13	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6309.76	54.32	20.92	6.97	3.78	19.46	4.36	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	5881.00	43.96	15.45	6.39	5.06	4.80	3.46	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3920.50	27.14	7.00	14.88	2.19	2.63	0.44	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	3942.65	31.42	5.47	7.74	2.73	4.10	2.28	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	4144.07	41.02	12.68	14.17	3.73	4.48	5.97	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	9227.90	61.95	14.77	10.08	8.64	11.16	5.04	2.52
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8835.06	63.87	26.18	13.52	8.06	19.28	5.47	5.18
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8556.02	62.93	21.68	10.13	9.43	14.61	5.42	4.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	8164.71	52.61	17.43	9.82	11.41	6.34	3.49	4.44
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	7354.15	58.74	30.76	13.53	9.23	9.23	4.92	3.69
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	7325.65	49.05	14.11	6.09	10.90	7.05	1.28	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	5141.49	38.25	11.86	3.82	3.82	4.21	2.29	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5146.61	35.86	18.52	7.49	1.97	5.52	3.55	2.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	5005.94	43.87	16.64	6.05	5.29	9.83	2.27	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	2351.86	16.06	8.83	1.61	3.21	2.41	1.61	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	2306.72	22.38	6.29	2.10	0.70	6.29	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	2470.32	27.05	9.02	6.01	1.00	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	3211.34	16.45	16.45	12.79	0.00	7.31	21.93	7.31
Cardiac Myocyte, donor2	11605-120I3	4204.70	21.74	10.38	5.93	5.93	2.47	2.47	2.96
Cardiac Myocyte, donor3	11686-122I3	6568.94	18.73	11.79	7.26	5.47	7.26	2.10	4.00
Chondrocyte - de diff, donor1	11261-116G1	5263.79	24.96	8.32	10.75	10.40	5.55	19.07	5.20
Chondrocyte - de diff, donor2	11338-117F6	4054.14	23.81	11.73	7.82	9.24	4.98	0.00	1.78
Chondrocyte - de diff, donor3	11410-118E6	3375.25	14.45	7.40	7.96	5.80	8.87	5.46	3.07
Chondrocyte - re diff, donor2	11339-117F7	2057.30	30.44	6.27	3.58	4.48	0.90	0.00	4.48
Chondrocyte - re diff, donor3	11411-118E7	2334.22	16.58	10.92	3.64	4.85	2.43	0.81	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	8058.21	37.07	21.12	14.34	7.92	8.26	2.75	6.66
Ciliary Epithelial Cells, donor2	11323-117D9	7402.70	38.26	22.02	7.91	12.61	9.62	6.20	6.84
Ciliary Epithelial Cells, donor3	11399-118D4	7851.17	36.64	18.94	10.80	12.12	10.53	4.69	8.85
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	4325.79	22.10	5.32	6.33	7.24	3.58	1.28	2.84
Corneal Epithelial Cells, donor1	11526-119I5	8570.79	24.37	16.03	12.74	5.27	2.85	2.20	5.71
Corneal Epithelial Cells, donor2	11606-120I4	4842.76	6.83	9.10	11.38	0.00	1.14	2.28	1.14
Corneal Epithelial Cells, donor3	11687-122I4	7014.76	17.89	8.95	4.86	9.46	11.50	4.09	4.86
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	9918.44	35.00	21.13	21.30	7.43	13.70	16.34	9.58
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9336.44	31.23	31.54	25.23	6.31	10.72	12.30	8.20
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	9365.20	24.15	13.80	6.90	0.00	0.00	0.00	6.90
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	9149.64	35.53	30.24	22.03	19.76	11.66	7.78	13.17
Dendritic Cells - plasmacytoid, donor1	11228-116C4	4586.88	6.83	9.91	6.15	2.39	6.15	1.37	3.42
Dendritic Cells - plasmacytoid, donor2	11309-117C4	5122.42	4.57	8.49	3.92	0.65	1.31	1.31	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	4040.94	3.39	6.29	0.97	2.42	2.42	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	7821.46	45.36	17.18	11.17	8.84	4.17	2.67	7.34
Endothelial Cells - Aortic, donor1	11263-116G3	5484.01	34.62	13.50	2.35	4.69	2.35	1.17	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	6946.35	32.24	10.18	6.50	4.81	1.98	3.68	3.68
Endothelial Cells - Aortic, donor3	11412-118E8	5427.51	49.54	15.73	6.68	6.68	0.39	1.18	6.29
Endothelial Cells - Artery, donor1	11264-116G4	5108.61	28.51	4.36	6.11	9.60	7.27	5.82	2.62
Endothelial Cells - Artery, donor2	11341-117F9	7443.26	32.00	14.59	7.29	18.35	12.23	5.88	7.76
Endothelial Cells - Artery, donor3	11413-118E9	9251.94	52.42	17.53	6.66	17.18	5.43	2.10	8.59
Endothelial Cells - Lymphatic, donor1	11236-116D3	3459.77	17.73	9.75	5.54	3.99	2.66	3.10	2.88
Endothelial Cells - Lymphatic, donor2	11317-117D3	3845.33	22.21	10.35	4.56	3.04	2.74	3.96	2.43
Endothelial Cells - Lymphatic, donor3	11393-118C7	3897.31	14.38	8.74	4.51	3.66	2.54	1.97	2.26
Endothelial Cells - Microvascular, donor1	11265-116G5	6335.48	26.44	9.51	7.13	7.13	3.86	14.26	2.97
Endothelial Cells - Microvascular, donor2	11342-117G1	4616.73	24.99	15.10	7.81	8.85	1.56	4.17	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	5412.00	24.10	9.36	8.22	12.19	14.04	6.66	4.96
Endothelial Cells - Thoracic, donor1	11266-116G6	6856.45	30.81	12.80	9.20	6.00	8.00	8.80	6.40
Endothelial Cells - Thoracic, donor2	11343-117G2	4653.18	20.44	11.01	11.53	8.39	5.77	2.62	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	6615.25	34.29	10.93	10.31	12.05	6.21	2.98	4.85
Endothelial Cells - Umbilical vein, donor2	11324-117E1	4250.73	27.16	9.99	7.17	9.34	2.61	2.39	2.17
Endothelial Cells - Umbilical vein, donor3	11400-118D5	5035.44	37.13	14.04	11.60	6.11	1.47	2.08	4.03
Endothelial Cells - Vein, donor1	11267-116G7	7776.00	45.50	7.96	3.41	7.96	2.28	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	9671.44	62.87	10.48	3.49	5.59	0.00	1.40	1.40
Endothelial Cells - Vein, donor3	11416-118F3	6054.82	41.61	12.56	6.12	11.62	6.12	2.98	4.40
Eosinophils, donor1	12244-129H3	8065.63	45.74	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13778.05	21.45	24.75	8.25	8.25	14.85	1.65	4.95
Eosinophils, donor3	12246-129H5	13204.38	10.70	32.10	14.27	0.00	7.13	0.00	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	6651.78	16.13	10.99	10.02	2.93	6.35	1.22	2.44
Esophageal Epithelial Cells, donor2	11587-120G3	3848.30	14.56	8.32	6.24	10.40	2.08	4.16	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	3367.64	32.54	16.27	32.54	0.00	65.08	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	5095.72	37.36	35.71	19.70	11.49	11.08	12.32	12.73
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3531.99	62.30	69.42	20.47	23.32	34.60	9.85	13.25
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4427.44	34.23	20.37	8.02	15.38	33.26	6.39	4.66
Fibroblast - Aortic Adventitial, donor1	11245-116E3	7620.02	44.02	14.92	18.92	17.71	14.31	6.67	5.22
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	4195.26	24.02	6.82	3.55	3.82	3.28	2.32	3.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	5437.03	28.16	10.34	9.39	20.36	8.12	5.38	7.91
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	2966.11	19.50	8.96	2.37	8.17	3.69	7.64	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	6158.65	39.86	7.97	14.62	15.28	13.95	8.97	6.64
Fibroblast - Cardiac, donor1	11268-116G8	6307.23	26.76	14.06	9.53	12.25	10.43	4.99	5.90
Fibroblast - Cardiac, donor2	11345-117G4	13314.12	64.43	36.38	9.85	11.37	10.61	12.89	7.58
Fibroblast - Cardiac, donor3	11417-118F4	5556.03	27.60	10.88	10.09	15.46	9.78	3.63	5.36
Fibroblast - Cardiac, donor4	11452-119A3	3732.77	20.01	5.76	3.64	3.64	2.42	0.91	1.82
Fibroblast - Cardiac, donor5	11456-119A7	3637.96	20.56	7.74	3.81	19.16	5.33	3.93	4.06
Fibroblast - Cardiac, donor6	11460-119B2	4641.05	24.56	10.91	3.79	15.92	7.28	5.00	4.24
Fibroblast - Choroid Plexus, donor1	11492-119E7	6120.55	25.73	6.97	5.09	4.96	2.81	2.95	3.48
Fibroblast - Choroid Plexus, donor2	11572-120E6	3338.82	17.69	7.33	4.31	3.88	3.02	2.16	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	7972.87	24.90	24.90	19.04	4.39	14.65	4.39	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	4178.72	13.84	4.61	3.69	0.92	3.23	0.46	2.08
Fibroblast - Conjunctival, donor3	11692-122I9	3818.81	8.31	4.75	3.05	1.36	2.88	1.36	1.19
Fibroblast - Dermal, donor1	11269-116G9	2974.68	17.37	2.82	2.82	7.75	8.22	8.22	1.64
Fibroblast - Dermal, donor2	11346-117G5	7053.96	37.73	17.92	6.60	6.60	1.89	2.83	2.36
Fibroblast - Dermal, donor3	11418-118F5	3775.63	15.11	7.37	5.92	6.89	9.43	7.25	4.23
Fibroblast - Dermal, donor4	11450-119A1	4084.78	20.46	8.25	3.39	16.05	4.18	3.84	3.62
Fibroblast - Dermal, donor5	11454-119A5	4320.51	27.74	10.29	2.09	14.65	4.19	5.41	4.71
Fibroblast - Dermal, donor6	11458-119A9	5089.21	25.99	12.67	4.22	15.11	2.60	6.82	3.25
Fibroblast - Gingival, donor1	11237-116D4	3866.83	19.99	9.58	4.79	2.29	3.96	1.87	2.50
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	7388.91	52.66	18.34	11.27	19.65	6.55	3.41	5.76
Fibroblast - Gingival, donor2	11318-117D4	5280.18	28.73	11.33	6.19	13.71	6.19	5.67	5.80
Fibroblast - Gingival, donor3	11394-118C8	2467.16	13.73	4.06	1.84	5.51	1.26	0.39	1.93
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	6016.23	27.01	17.66	22.86	14.54	7.27	4.16	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	5499.84	25.20	20.97	13.57	17.62	11.63	4.76	4.93
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	8032.25	43.18	17.93	10.91	11.38	6.24	2.81	5.92
Fibroblast - Gingival, donor6 (control)	11922-125H5	7169.89	41.65	24.21	8.65	9.60	7.44	3.25	5.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16842.93	73.05	24.70	7.06	18.00	6.70	0.35	5.29
Fibroblast - Gingival, donor7 (control)	11924-125H7	8266.91	41.24	20.18	12.28	13.75	9.07	4.68	6.14
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	6975.43	43.63	16.77	10.09	10.64	6.82	3.82	5.86
Fibroblast - Gingival, donor8 (control)	11926-125H9	9847.15	43.88	22.60	10.86	22.49	9.32	5.48	5.16
Fibroblast - Gingival, donor9 (control)	11927-125I1	5467.49	36.39	16.58	9.39	15.41	10.42	3.82	3.96
Fibroblast - Lung, donor1	11270-116H1	6897.34	35.34	9.52	5.44	14.95	5.44	4.08	2.72
Fibroblast - Lung, donor2	11347-117G6	3240.96	16.41	5.97	0.00	0.00	0.00	5.97	1.49
Fibroblast - Lung, donor3	11419-118F6	5887.69	25.54	14.14	5.91	8.23	12.66	4.01	5.49
Fibroblast - Lymphatic, donor1	11506-119G3	16195.61	34.15	20.83	5.00	0.00	1.67	3.33	6.66
Fibroblast - Lymphatic, donor2	11586-120G2	6046.27	15.38	5.59	1.40	8.39	4.20	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6458.13	13.15	13.43	6.16	6.44	1.96	3.92	1.68
Fibroblast - Mammary, donor1	11540-120B1	11579.45	32.07	7.71	3.65	4.06	2.44	0.81	3.25
Fibroblast - Mammary, donor2	11620-122A9	9522.19	23.97	27.96	11.98	0.00	7.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	8868.88	11.91	5.96	0.00	23.83	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	4949.82	34.92	12.61	8.92	3.88	6.79	1.36	4.07
Fibroblast - Periodontal Ligament, donor2	11319-117D5	5511.97	28.36	6.52	2.88	10.77	2.12	1.67	3.03
Fibroblast - Periodontal Ligament, donor3	11395-118C9	5657.71	30.60	7.34	1.84	2.14	2.14	2.75	2.45
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8090.80	30.91	20.23	18.32	14.50	2.67	3.43	5.72
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9821.16	40.23	25.38	23.49	23.22	16.47	9.99	10.26
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	5299.67	27.83	20.99	16.93	19.95	6.03	4.64	4.52
Fibroblast - Pulmonary Artery, donor1	11250-116E8	7509.03	36.03	15.03	18.13	5.86	12.38	3.65	5.75
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	13306.96	30.28	17.47	7.11	4.88	9.55	1.22	5.28
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	7357.58	22.72	18.04	12.70	10.02	6.68	4.01	6.68
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	4994.60	18.58	9.49	5.14	4.74	6.72	3.16	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	8482.64	23.02	10.52	4.17	11.91	8.93	16.27	2.78
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	4729.97	8.88	6.93	6.04	5.51	5.15	1.60	2.66
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	5757.05	13.99	10.45	6.50	3.94	4.14	1.58	3.35
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	5305.88	21.36	6.32	2.41	6.62	8.42	6.32	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	7150.82	17.38	9.39	4.86	12.85	2.91	6.05	3.45
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	7980.96	16.20	8.60	3.80	13.67	9.62	14.68	3.80
Fibroblast - skin normal, donor1	11553-120C5	6770.02	20.84	8.53	8.20	7.88	5.91	1.97	2.63
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	5703.83	27.87	12.63	11.23	3.01	6.82	3.01	4.21
Fibroblast - skin normal, donor2	11561-120D4	10305.31	27.73	10.15	6.03	20.19	7.03	7.84	3.32
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	9864.43	23.57	12.39	3.63	12.09	9.37	18.74	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	5821.67	14.17	7.95	7.37	5.55	4.47	2.65	3.07
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	2713.84	10.26	2.22	2.56	5.47	2.39	1.37	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	5824.74	20.69	9.20	2.63	4.60	4.60	6.90	3.28
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	11014.89	23.43	12.14	7.24	19.49	7.24	5.86	6.60
Fibroblast - skin walker warburg, donor1	11554-120C6	10988.88	29.52	16.53	15.86	6.41	9.78	3.04	4.22
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	5830.40	23.99	18.82	13.33	34.81	143.49	8.31	9.88
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	3966.60	22.16	44.32	66.48	0.00	265.92	66.48	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	1857.23	5.23	3.49	5.23	6.97	1.74	1.74	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	6632.31	23.40	19.42	10.57	9.19	8.67	5.03	3.81
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	7448.35	17.70	17.70	14.57	8.59	8.85	3.90	7.81
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	6419.50	25.81	11.50	15.59	9.20	5.88	5.62	4.85
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	5848.82	38.28	19.14	26.03	9.95	40.57	9.19	7.66
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	6353.28	54.87	29.35	40.20	15.95	38.28	10.21	9.57
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	4218.77	33.66	19.40	47.64	9.41	64.75	19.40	5.13
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	3784.77	24.54	13.79	42.47	22.61	104.79	22.06	6.34
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	2804.08	23.52	13.70	40.41	17.58	81.51	12.33	6.16
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	4150.04	29.52	13.87	45.77	12.48	58.65	15.45	6.34
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	3999.65	28.02	19.83	40.97	18.24	112.34	31.46	4.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	2965.00	19.24	7.18	42.73	11.74	60.66	11.09	6.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3621.37	34.49	7.96	28.74	8.84	40.24	11.06	7.96
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	6056.22	21.48	7.21	4.24	8.20	8.62	2.69	3.53
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	5245.25	22.66	8.13	3.45	11.45	7.63	4.06	3.82
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5148.47	23.91	13.43	10.75	9.67	10.48	4.84	5.10
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	7416.27	28.62	9.42	7.81	17.35	9.29	7.06	3.96
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	7811.26	31.98	9.41	4.57	12.87	9.14	5.40	3.46
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	5415.38	29.28	12.60	9.35	9.35	16.26	5.08	5.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	4723.98	26.93	13.69	9.36	6.85	13.23	6.16	3.88
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	5431.32	26.28	5.36	4.11	13.20	5.98	4.11	2.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	4936.11	23.17	9.84	5.25	7.87	6.78	4.37	2.84
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	4391.71	16.55	10.05	7.68	7.68	8.86	3.55	3.55
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	5508.70	20.98	7.31	3.81	6.04	4.93	6.52	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	4153.82	18.54	8.04	4.02	5.36	8.04	3.35	2.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	4602.08	23.99	7.46	10.28	8.07	11.49	5.44	4.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	5403.10	19.51	5.43	2.88	10.69	5.94	3.73	2.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	5766.35	24.92	7.09	4.34	5.94	7.18	3.28	3.01
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	5401.66	36.21	6.87	7.28	6.76	5.41	1.56	3.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	5191.77	38.60	6.66	5.29	5.81	4.95	1.37	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	4427.70	18.26	5.64	2.32	9.18	6.20	4.32	2.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	4596.68	18.05	6.57	5.32	3.24	5.32	1.75	2.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	4217.36	21.03	6.13	5.72	2.65	3.06	1.43	2.25
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	4044.62	16.09	6.60	8.66	8.46	11.97	5.78	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	4546.60	17.06	4.15	4.38	6.11	5.76	2.77	1.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	3823.92	16.84	7.50	5.17	6.34	8.51	3.34	3.34
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	3486.55	19.18	5.73	6.39	6.39	11.02	4.19	3.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	3896.14	20.79	6.40	3.32	9.84	7.13	5.66	2.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	3695.07	14.75	6.00	3.73	6.32	6.48	3.73	2.11
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	3002.21	10.90	9.30	6.09	5.77	7.38	3.21	3.21
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	4327.15	18.48	5.21	2.08	8.72	7.39	3.88	1.23
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	3521.16	19.14	7.12	4.59	3.32	6.96	2.69	3.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	3905.40	18.85	7.60	8.51	6.39	10.95	6.99	2.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	4381.83	21.74	7.42	4.81	8.78	9.20	5.02	2.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	2972.77	14.27	5.93	2.63	3.73	5.05	4.39	1.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	3625.81	16.27	7.57	4.77	4.49	7.57	3.09	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	4619.35	26.57	4.17	3.52	9.44	3.33	0.93	1.30
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	3670.12	18.99	9.63	4.55	3.21	4.81	6.42	2.94
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	4165.11	25.86	6.73	4.74	4.44	5.20	3.06	2.45
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	4789.63	18.01	4.15	2.07	10.23	6.87	5.57	2.59
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	3234.98	14.91	6.78	3.52	5.69	6.78	2.44	2.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	4574.86	21.57	8.11	8.30	9.77	8.30	4.98	3.87
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	4784.74	23.03	10.97	6.14	7.24	10.09	5.04	2.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	3544.50	15.87	6.94	1.98	2.98	3.97	0.00	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	6230.21	24.27	10.16	8.05	7.26	8.71	5.67	3.30
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	5593.92	20.58	10.29	11.10	7.67	8.47	5.45	4.84
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	4621.39	23.64	4.57	0.76	3.56	4.07	1.02	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	6645.02	27.27	15.33	7.56	10.95	8.16	8.16	3.38
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	5953.66	27.73	12.02	7.24	14.64	10.32	4.78	5.70
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	7449.68	25.16	4.50	2.86	5.11	4.50	2.66	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	6053.32	31.61	11.27	9.39	4.07	8.45	8.14	5.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	5870.37	30.52	16.39	9.32	4.52	10.74	8.48	5.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	4636.96	29.52	13.84	9.69	1.84	4.61	6.00	3.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	5937.04	27.22	22.27	14.85	12.37	19.80	7.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	5407.20	27.46	10.44	8.51	6.96	7.35	5.03	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	3956.62	25.67	28.88	14.44	1.60	6.42	8.02	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	4806.12	20.87	13.91	10.43	10.43	5.22	12.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	4161.58	19.53	12.69	11.72	5.86	8.14	3.91	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	4371.28	24.30	10.71	7.00	4.53	4.94	4.94	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	4431.92	26.66	29.99	19.99	19.99	23.33	13.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	3816.91	15.10	11.47	9.51	6.15	9.23	3.64	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	4303.88	18.63	8.82	7.19	2.94	6.86	5.56	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	3904.78	10.90	10.07	10.90	4.19	17.62	7.55	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	4065.28	18.77	8.91	8.91	4.45	6.36	4.45	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	4277.36	18.00	8.49	10.87	4.08	7.81	6.79	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	3508.09	10.44	14.62	10.44	2.09	16.71	8.35	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	4330.18	8.59	12.60	8.59	5.73	4.58	6.30	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	4043.42	11.84	13.32	10.95	4.14	6.22	5.03	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	3347.63	11.86	10.16	5.08	8.47	20.33	13.55	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	4326.81	15.33	10.77	8.28	8.28	7.04	4.56	3.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	4175.00	16.80	9.44	8.05	5.29	10.13	6.67	2.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	3666.87	21.07	15.81	0.00	0.00	36.88	15.81	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	3375.14	8.07	5.00	5.38	0.38	5.38	2.69	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	3137.14	11.73	6.52	5.87	2.61	5.87	3.26	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	2587.74	14.05	10.03	6.02	3.34	10.70	3.34	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	3022.43	9.25	6.55	3.08	3.85	8.09	3.08	2.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	5158.72	19.86	7.87	7.53	5.14	10.95	10.95	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	3267.50	9.94	4.97	2.48	9.94	14.91	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	2666.43	10.85	8.02	5.66	3.77	8.97	6.61	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	3027.73	8.45	9.66	9.66	5.43	7.85	5.43	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	3113.09	9.16	3.56	4.07	7.63	9.66	2.54	4.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	3211.85	12.36	3.59	7.98	7.18	12.36	5.98	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	2791.41	10.85	6.41	7.40	3.45	1.97	3.45	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	2641.83	15.35	12.98	8.26	0.00	10.62	7.08	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	3012.33	7.58	8.17	8.17	2.33	7.00	4.67	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	2707.90	10.53	4.83	2.19	1.32	3.95	2.19	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	2465.94	11.87	4.24	7.63	2.54	6.78	2.54	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	2662.24	3.58	4.78	8.36	1.19	5.37	2.98	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	2842.58	8.73	7.76	2.91	2.43	5.82	3.88	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10515.96	33.10	18.26	3.42	17.12	7.99	2.28	4.57
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9471.88	33.27	14.55	12.89	16.63	20.79	15.39	6.65
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	15922.26	84.33	42.73	11.24	42.73	6.75	1.12	10.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5425.67	15.22	7.29	7.61	6.98	9.20	4.76	2.54
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4837.87	17.96	8.35	6.27	3.34	7.10	2.92	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	5090.41	20.89	13.81	10.79	7.77	7.19	4.53	6.03
Hep-2 cells mock treated, biol_rep2	11899-125E9	5415.99	19.24	17.05	11.48	6.92	8.61	2.53	4.39
Hep-2 cells mock treated, biol_rep3	11900-125F1	5051.94	17.29	6.60	11.15	4.32	5.01	2.50	3.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	5432.10	20.22	16.29	9.73	11.04	9.95	5.90	7.54
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	5495.09	19.13	12.89	7.31	8.38	6.88	3.87	5.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	4965.27	16.36	10.76	10.12	4.31	6.24	3.66	4.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	4744.76	17.44	11.71	10.09	6.10	9.22	4.61	3.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	4590.84	18.87	11.49	9.78	3.95	5.49	3.95	2.40
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	4604.39	18.26	12.49	10.57	4.49	8.65	2.56	5.13
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	5601.27	37.49	8.95	6.72	23.50	2.80	7.28	6.16
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	11282.93	42.85	20.34	16.88	19.04	7.79	5.19	9.09
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2289.54	37.01	47.59	13.22	0.00	13.22	2.64	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	9411.67	38.80	21.16	15.52	5.64	7.76	1.76	4.94
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10625.24	21.80	14.53	16.71	8.72	10.17	8.72	6.54
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6249.96	32.52	16.61	15.21	6.82	7.52	5.59	3.85
Hepatocyte, donor1	11523-119I2	1131.91	7.26	6.05	2.42	1.21	3.63	3.63	0.00
Hepatocyte, donor2	11603-120I1	1907.96	5.39	5.39	4.31	0.00	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	1547.96	6.14	5.52	9.20	4.29	1.84	6.75	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	3740.55	28.07	11.75	7.18	1.96	4.57	3.26	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	3991.84	9.61	6.82	6.64	7.34	4.19	3.32	2.62
Iris Pigment Epithelial Cells, donor1	11530-119I9	4659.13	19.48	9.19	6.17	4.39	9.47	3.02	1.92
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3518.20	12.74	0.00	12.74	0.00	6.37	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	4098.64	6.68	13.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	1435.41	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	3334.96	8.31	0.00	1.38	8.31	1.38	2.77	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	4016.78	10.01	0.00	7.51	5.01	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	1602.22	35.60	23.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	3688.02	12.81	7.69	2.56	2.56	0.00	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	3862.30	36.57	4.57	4.57	0.00	9.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3761.94	12.99	14.62	0.00	0.00	3.25	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3171.22	15.01	0.00	1.67	3.33	1.67	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3398.21	14.52	14.52	3.63	0.00	3.63	0.00	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	3663.37	19.85	1.32	1.32	1.32	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3139.68	15.52	2.22	4.43	3.33	2.22	2.22	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	3960.14	10.48	15.71	10.48	10.48	5.24	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3579.51	17.64	6.30	0.63	6.30	2.52	0.00	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3240.18	12.37	4.64	7.73	3.09	1.55	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	2839.14	14.63	43.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	4209.58	18.74	10.98	1.29	6.46	2.58	1.94	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3638.43	9.66	3.22	1.61	3.22	1.61	1.61	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	2939.26	11.95	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4047.50	17.93	4.89	0.00	4.89	2.44	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4156.12	16.79	2.10	0.42	2.52	1.26	0.42	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	2874.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	3885.82	13.66	0.80	2.41	4.02	1.61	2.41	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2853.86	11.08	3.69	0.92	0.92	1.85	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	2277.20	0.00	30.16	0.00	0.00	0.00	30.16	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3631.86	14.63	7.55	1.42	3.78	2.83	2.36	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2760.85	11.79	7.26	5.44	3.63	9.07	4.53	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	2653.64	29.48	14.74	0.00	14.74	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3931.06	12.91	6.46	5.38	5.38	5.38	4.30	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3957.50	12.70	2.54	5.08	7.62	2.54	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	2941.03	32.86	0.00	16.43	0.00	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	4343.23	16.58	4.46	1.28	7.65	2.55	0.00	3.83
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3470.35	18.23	3.65	0.00	3.65	0.00	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	2528.70	0.00	31.61	0.00	0.00	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	4694.26	12.14	7.85	4.28	2.14	2.14	1.43	5.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3086.03	16.59	0.00	3.32	6.64	3.32	6.64	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	2084.86	0.00	20.85	0.00	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	3639.10	14.20	4.94	1.23	6.17	3.70	0.62	4.01
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3282.01	10.54	5.27	3.51	3.51	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3438.58	6.29	6.29	0.00	0.00	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4074.97	15.30	7.65	0.70	6.26	3.48	1.39	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4282.34	19.92	8.85	4.43	2.21	4.43	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3109.09	3.24	0.00	3.24	0.00	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	4334.37	19.18	5.23	0.00	6.10	1.74	0.87	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	3718.89	18.00	6.75	2.25	11.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3543.81	10.45	17.42	0.00	17.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4397.24	11.73	5.33	2.13	5.33	2.13	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	3749.01	11.08	2.77	0.00	2.77	4.16	2.77	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2792.61	25.65	5.70	0.00	2.85	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3931.14	18.41	9.20	1.84	1.84	2.76	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3503.32	3.03	3.03	3.03	9.08	6.05	6.05	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	3445.82	12.42	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	3482.98	13.75	0.00	2.11	6.34	2.11	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	7093.74	19.99	8.89	9.14	12.24	8.98	4.24	3.67
Keratinocyte - epidermal, donor2	11349-117G8	8439.59	22.84	14.06	6.44	4.10	4.10	1.76	3.51
Keratinocyte - epidermal, donor3	11421-118F8	7663.54	13.73	12.97	8.99	8.80	14.01	7.67	5.58
Keratinocyte - oral, donor1	11251-116E9	6779.60	26.45	9.99	13.96	7.04	5.79	2.61	4.77
Keratocytes, donor1	11527-119I6	2896.78	9.97	5.50	3.09	2.75	1.72	0.00	3.09
Keratocytes, donor2	11607-120I5	4939.14	33.98	8.20	10.55	4.69	1.17	1.17	3.52
Keratocytes, donor3	11688-122I5	1351.37	7.51	1.78	2.17	1.19	2.37	0.40	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	1340.73	13.19	2.20	28.57	0.00	0.00	4.40	4.40
Lens Epithelial Cells, donor1	11529-119I8	6218.96	29.13	15.10	8.63	7.55	11.87	4.31	2.16
Lens Epithelial Cells, donor2	11609-120I7	4711.42	14.65	7.15	5.77	2.54	2.31	0.92	2.19
Lens Epithelial Cells, donor3	11690-122I7	7316.65	45.21	6.96	4.84	3.43	5.55	0.81	2.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	5381.38	26.32	11.86	6.52	7.83	6.64	2.61	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	4401.84	17.86	10.88	11.44	5.86	7.54	3.07	5.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	4208.57	17.63	12.44	6.14	11.02	6.61	4.25	3.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	4462.50	24.20	16.67	11.29	3.23	6.99	5.91	4.30
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4611.50	22.06	16.39	5.67	5.04	10.72	3.78	5.67
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4269.12	17.14	11.00	7.87	7.22	7.01	3.56	4.74
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	4158.09	21.75	14.77	6.16	1.23	5.34	3.69	3.69
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4896.61	17.70	7.84	9.61	3.79	7.08	1.52	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4195.07	18.44	9.85	7.46	10.27	5.07	3.38	2.96
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3867.12	14.24	11.47	3.96	2.37	1.98	2.77	2.77
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	3943.79	16.29	8.72	8.34	6.01	6.79	3.10	3.88
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4275.26	18.51	12.96	6.67	8.89	3.70	4.07	4.26
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	4428.82	20.21	8.01	9.41	6.62	7.32	1.05	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	4680.31	18.60	9.78	7.87	3.34	5.25	3.10	3.34
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4303.94	19.09	13.87	6.04	6.04	6.32	2.88	2.88
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	4086.30	16.32	8.31	11.09	3.70	4.93	2.77	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4772.49	21.51	18.39	5.30	4.99	7.79	3.43	5.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5102.15	21.96	9.52	6.77	6.59	5.49	3.66	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	4588.79	23.37	13.16	6.58	3.62	6.25	3.29	3.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4776.45	20.21	16.99	7.32	2.34	5.56	4.39	5.86
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5056.24	22.90	16.93	9.46	7.22	5.73	4.98	5.23
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	4710.45	22.31	10.18	10.67	5.82	5.33	2.42	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4241.42	20.47	12.66	8.08	3.77	8.35	4.58	2.96
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	4303.97	18.17	10.29	7.42	8.63	4.54	4.84	3.33
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4176.33	20.22	9.33	6.22	0.52	3.11	2.07	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	4074.12	16.54	10.26	8.79	5.65	9.00	2.93	3.98
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4285.75	13.23	10.83	6.01	5.56	5.41	3.91	3.61
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4196.73	18.57	11.01	4.13	2.75	4.13	4.13	3.44
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3987.62	16.18	9.03	7.90	6.40	7.34	3.39	4.33
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4395.36	19.30	8.27	7.74	7.53	6.47	4.67	3.92
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3786.01	18.41	12.11	6.78	3.39	5.81	2.91	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3680.03	18.19	8.60	5.29	5.29	4.96	2.65	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4230.78	21.43	10.65	5.58	9.17	5.58	4.58	3.47
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	3787.25	16.29	7.77	6.29	2.59	2.96	1.85	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3934.05	19.52	9.88	3.95	2.96	3.71	2.72	3.95
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4192.32	18.01	12.79	5.09	7.70	5.91	2.47	3.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	4039.78	17.37	9.33	7.40	2.57	3.54	3.54	2.57
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	4182.40	22.82	12.48	6.39	4.56	7.30	0.61	3.65
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	3777.26	15.96	9.38	6.58	6.72	5.74	3.36	3.08
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	3963.09	20.27	12.44	7.11	1.78	5.33	5.33	3.20
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4155.02	16.97	10.67	3.39	2.42	6.79	0.97	2.91
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4473.26	23.81	13.69	6.85	8.56	7.62	4.36	3.58
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4070.58	23.99	11.82	13.25	7.52	7.52	2.15	3.22
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4377.77	15.68	11.76	5.88	2.61	4.57	2.61	2.94
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4220.21	16.72	13.18	7.06	5.18	6.12	4.94	4.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	4622.50	30.07	7.80	6.19	6.93	4.33	2.85	1.73
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4205.61	17.42	11.27	6.92	5.63	7.43	3.07	3.33
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	3531.95	17.60	9.85	12.23	9.85	6.27	4.18	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	5313.79	4.53	6.80	0.00	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	4971.02	13.04	10.74	6.14	10.74	6.14	3.84	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	4496.41	11.88	9.65	3.71	3.71	8.91	3.71	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	5626.34	29.62	34.70	7.19	6.35	10.16	5.50	8.46
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4815.65	14.07	7.03	5.63	12.66	10.55	1.41	5.63
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4907.99	18.68	8.41	5.60	3.74	9.34	2.80	4.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4974.92	21.13	35.55	9.27	6.70	11.34	10.31	6.70
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4845.86	15.46	8.33	7.14	13.08	4.76	2.38	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	5707.30	13.12	7.24	1.81	4.30	5.20	2.04	2.49
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	4411.56	19.19	14.54	10.47	7.27	10.76	6.11	5.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	4389.20	13.51	12.15	9.45	6.30	8.55	5.85	4.05
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	7144.72	21.68	10.43	3.93	8.67	4.47	2.03	4.88
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	5463.89	24.65	23.11	8.73	8.73	7.70	5.14	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	4201.45	12.00	8.82	7.76	10.59	7.41	3.53	2.82
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	3851.91	9.33	3.33	8.00	6.66	8.66	2.67	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	5315.44	19.87	20.38	9.68	6.11	6.62	9.17	4.58
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	4227.00	15.74	12.01	8.00	7.20	6.40	3.47	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	4435.86	13.79	10.01	4.35	5.29	4.53	3.02	5.10
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	5314.07	17.79	25.77	3.68	5.52	9.20	4.29	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	5961.56	26.09	9.79	7.34	15.49	18.75	8.15	4.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	4377.90	18.33	13.33	5.41	8.12	7.08	5.00	5.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	4057.90	22.42	19.90	10.09	5.61	10.09	7.57	5.61
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	5150.67	25.76	24.73	5.15	5.15	9.27	1.03	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	4561.55	22.06	14.22	6.10	8.71	11.90	4.94	5.23
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	4059.17	18.23	16.44	5.98	3.59	5.98	5.08	5.38
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	3821.90	16.04	7.75	9.96	13.28	7.19	4.43	3.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	5764.32	20.15	16.26	5.30	10.25	10.96	4.60	6.01
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	5048.60	16.96	19.55	4.06	11.43	7.01	2.95	4.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	4521.06	17.27	10.36	10.36	17.27	4.61	1.15	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	5705.64	18.42	13.05	3.07	4.61	6.52	3.84	3.07
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	5530.53	27.74	24.34	7.93	14.15	14.72	6.23	7.93
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5073.78	13.13	10.67	7.38	10.67	7.38	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	6065.18	15.82	18.53	6.33	8.13	7.23	1.81	3.16
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5531.86	22.26	17.95	7.18	5.03	10.77	2.87	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	5239.53	19.42	14.19	5.98	8.96	13.44	1.49	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	6575.71	26.75	15.98	2.23	8.55	9.66	4.09	7.06
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	5229.70	25.84	13.35	7.75	4.31	5.17	3.45	4.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5827.96	10.28	17.13	5.99	12.84	8.56	5.14	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	6291.71	21.66	14.99	4.66	7.33	10.00	3.66	4.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	5717.55	16.29	13.27	11.46	6.03	6.64	3.02	5.43
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	5307.60	19.20	9.24	10.66	10.66	7.82	4.27	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	5686.12	16.15	16.50	5.84	14.09	9.28	5.50	4.47
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6040.02	24.15	17.18	13.42	6.44	8.59	6.44	6.44
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	5772.05	23.57	13.47	8.75	9.43	16.16	2.02	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	6310.64	27.04	22.97	6.30	14.45	13.33	3.70	8.15
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	5266.91	24.42	15.12	3.49	0.00	6.98	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	5167.07	11.64	13.75	4.23	5.29	6.35	5.29	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	5766.18	25.21	20.41	7.20	8.40	11.20	3.60	4.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5381.04	19.63	16.72	4.36	4.36	8.00	2.18	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6574.41	37.56	15.33	8.43	9.96	10.73	0.77	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6093.95	19.24	18.25	3.95	9.87	9.87	5.92	4.44
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5402.83	17.88	10.35	6.59	1.88	4.70	7.53	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	6525.61	20.62	16.09	8.05	13.07	7.54	1.01	6.54
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	5827.92	25.69	14.87	3.15	8.56	6.76	3.60	3.15
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5078.98	29.26	24.10	6.88	5.16	5.16	1.72	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	6603.54	26.72	13.36	12.91	11.13	15.59	6.68	8.46
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	6430.81	25.81	16.03	4.30	6.65	8.21	1.96	4.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5537.16	17.15	19.79	2.64	7.26	11.88	7.26	5.28
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	6496.95	23.35	20.24	9.86	10.38	9.34	2.08	6.23
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	6904.80	22.32	17.94	4.38	13.13	9.19	2.19	7.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	5307.55	17.33	17.89	4.47	7.83	6.71	4.47	4.47
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	6077.87	24.29	25.17	8.83	8.83	7.51	3.53	5.30
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	5734.43	23.14	16.20	4.63	8.49	7.33	4.63	5.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	5326.34	20.76	16.20	6.58	6.08	5.57	2.53	4.56
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	5745.33	27.40	18.26	7.69	8.65	8.65	2.88	4.33
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	5742.96	30.21	13.52	2.39	7.95	5.57	3.58	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	4292.85	24.91	20.66	7.29	7.90	6.68	3.65	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	5927.89	17.98	14.53	6.92	24.21	13.83	8.99	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	5890.24	23.18	13.68	6.46	11.40	9.88	5.32	5.32
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5423.93	24.79	17.04	8.78	6.20	9.30	7.75	4.13
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6614.93	21.16	22.98	4.84	18.74	7.26	8.47	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	5708.65	30.42	15.53	2.85	9.82	6.34	4.12	5.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	5691.79	25.59	10.66	5.33	2.13	3.73	4.80	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	6867.89	21.84	18.96	7.47	13.22	8.05	6.32	5.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	6335.36	33.43	24.17	5.14	10.28	16.46	5.66	9.26
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	6567.78	26.88	18.39	4.24	7.07	9.20	2.12	4.95
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7555.52	26.10	14.75	5.11	12.48	13.62	11.92	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	6345.63	33.28	18.72	5.41	9.15	9.15	5.41	4.58
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	6605.74	28.19	31.32	10.18	10.18	8.61	5.48	6.26
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7472.84	17.12	15.45	4.59	13.78	8.35	7.93	2.51
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6725.16	31.13	11.62	3.72	7.90	6.50	5.58	6.50
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6696.50	30.11	16.06	5.35	8.03	7.36	6.02	6.69
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9435.37	25.13	27.80	4.81	21.39	8.02	9.62	5.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	7777.63	32.33	22.23	5.25	15.76	13.34	2.42	6.87
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	6745.55	26.62	13.77	8.26	3.67	9.18	0.92	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8100.67	36.45	21.34	6.22	18.67	7.11	9.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	7897.82	38.18	23.36	4.56	24.50	11.40	3.42	9.12
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	8350.76	34.51	19.17	6.90	6.90	7.67	3.07	5.37
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9717.86	38.30	26.26	9.30	22.43	15.32	14.77	8.21
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	9100.49	36.08	20.94	4.45	12.47	9.35	3.56	4.90
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	10812.57	41.59	12.22	6.24	16.12	6.76	2.60	5.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11161.41	43.77	29.84	5.30	28.51	13.26	10.61	3.32
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8177.25	54.04	37.41	12.47	8.31	16.63	2.08	12.47
Macrophage - monocyte derived, donor1	11232-116C8	6548.01	10.48	19.14	19.60	6.15	9.12	9.12	7.52
Macrophage - monocyte derived, donor2	11313-117C8	9206.56	22.94	23.31	13.21	8.07	6.24	5.51	8.26
Macrophage - monocyte derived, donor3	11389-118C3	10286.46	31.33	34.08	24.77	20.58	9.96	6.82	10.88
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5730.25	17.52	7.97	6.37	0.53	8.50	0.00	7.97
Mallassez-derived cells, donor2	11929-125I3	8040.34	11.41	8.56	6.34	6.65	4.28	1.27	3.01
Mallassez-derived cells, donor3	11930-125I4	8869.62	13.76	11.54	9.31	6.95	4.31	1.39	3.20
Mammary Epithelial Cell, donor1	11273-116H4	4089.37	15.64	6.58	7.97	3.69	3.59	1.99	2.09
Mammary Epithelial Cell, donor2	11350-117G9	4164.59	13.03	4.34	4.05	3.19	4.92	1.16	1.45
Mammary Epithelial Cell, donor3	11422-118F9	10338.49	32.43	17.46	3.74	11.47	2.00	2.00	4.74
Mast cell - stimulated, donor1	11487-119E2	3946.27	33.90	10.17	2.03	11.52	2.71	0.68	0.68
Mast cell, donor1	11563-120D6	4139.74	23.47	7.35	22.06	14.38	4.33	4.65	3.14
Mast cell, donor2	11565-120D8	4749.44	36.26	13.97	24.37	49.03	10.10	3.86	2.97
Mast cell, donor3	11566-120D9	3794.92	36.02	15.53	28.14	34.44	6.30	5.40	3.60
Mast cell, donor4	11567-120E1	4814.46	43.79	13.47	31.03	72.51	6.56	3.55	4.43
Mast cell, expanded and stimulated, donor5	11940-126A5	6632.84	17.30	8.98	14.64	10.65	8.76	9.32	3.66
Mast cell, expanded and stimulated, donor8	11942-126A7	2920.75	21.60	8.17	8.17	5.25	5.25	7.59	0.00
Mast cell, expanded, donor5	11939-126A4	5507.58	21.80	10.21	25.81	13.54	10.32	4.82	2.06
Mast cell, expanded, donor8	11941-126A6	3320.23	19.92	6.86	12.05	5.02	8.03	5.69	0.84
Melanocyte - dark, donor1	11502-119F8	4720.88	11.54	7.16	7.06	3.78	4.08	2.09	2.39
Melanocyte - dark, donor2	11582-120F7	4219.79	19.73	13.50	7.27	3.46	7.61	6.23	3.11
Melanocyte - dark, donor3	11663-122F7	4595.07	39.84	7.39	5.65	3.62	3.62	2.17	2.83
Melanocyte - light, donor1	11274-116H5	4368.11	39.26	6.58	7.29	14.34	6.11	1.41	2.12
Melanocyte - light, donor2	11351-117H1	6360.58	50.50	16.38	5.46	13.65	4.78	1.36	2.73
Melanocyte - light, donor3	11423-118G1	5104.47	49.43	19.95	8.67	9.54	10.41	6.94	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	4722.29	20.30	6.56	4.89	9.27	7.08	3.44	3.85
Melanocyte, donor2 (MC+2)	12739-135I3	3177.28	18.56	17.48	5.38	1.88	6.19	2.96	3.50
Melanocyte, donor3 (MC+3)	12837-137B2	2577.03	9.91	5.62	4.29	2.95	4.29	2.95	1.34
Meningeal Cells, donor1	11493-119E8	12372.85	58.80	9.18	2.48	6.95	2.85	3.47	3.23
Meningeal Cells, donor2	11573-120E7	7851.79	32.57	8.80	3.96	17.61	4.40	2.64	9.24
Meningeal Cells, donor3	11654-122E7	9457.94	60.64	11.00	6.76	5.54	4.97	1.87	2.85
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	5963.47	24.81	13.69	13.69	3.71	11.69	3.14	3.42
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	2798.28	19.22	4.13	2.82	2.72	2.52	1.11	1.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10024.45	17.08	9.20	3.94	7.88	2.63	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	8070.05	31.40	30.09	11.77	2.62	2.62	5.23	5.23
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5406.44	27.99	15.07	6.46	2.15	5.02	7.89	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	6894.11	27.11	9.11	12.07	12.07	6.35	2.96	4.24
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	8369.05	35.19	21.61	19.10	9.55	9.05	15.58	4.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	8501.36	37.36	12.09	15.60	3.96	5.71	0.66	6.15
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8028.43	31.42	19.73	16.07	7.31	8.04	6.58	10.23
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7765.50	32.53	13.50	6.96	15.14	9.41	4.09	4.50
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	4830.99	8.03	8.31	3.60	3.60	3.74	3.19	1.94
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	6856.82	22.30	16.36	7.43	5.20	2.97	1.12	2.97
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	6033.73	11.58	8.16	7.24	4.08	5.92	1.58	2.89
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	1296.75	15.13	2.08	1.19	0.30	1.48	0.59	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2459.33	11.68	4.67	2.34	2.34	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	9676.45	35.86	18.57	8.33	10.25	8.97	4.48	5.12
Mesenchymal stem cells - adipose, donor0	11217-116B2	6459.04	25.52	10.99	17.72	5.67	8.86	3.90	2.84
Mesenchymal stem cells - hepatic, donor0	11218-116B3	6049.96	12.20	9.07	12.20	7.51	7.51	2.50	4.69
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5780.14	18.87	7.98	13.06	4.35	11.61	7.26	5.08
Mesothelial Cells, donor1	11247-116E5	3860.42	14.32	5.83	10.34	7.16	5.57	1.33	3.18
Mesothelial Cells, donor2	12156-128G5	5385.02	25.52	5.51	2.50	5.00	2.50	1.50	3.00
Mesothelial Cells, donor3	11402-118D7	4185.13	17.20	7.30	9.90	8.60	5.28	4.26	5.13
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8651.52	47.26	10.80	33.76	1.35	4.05	8.10	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6833.13	20.19	21.92	42.11	20.44	9.36	12.31	9.60
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7159.47	25.62	23.26	12.66	7.07	4.71	5.30	5.89
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6060.26	20.74	3.46	3.46	0.00	0.00	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	5026.10	14.88	18.91	28.52	7.75	6.51	7.75	8.68
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	5765.18	18.67	16.59	13.07	5.19	8.30	3.94	4.98
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4868.33	23.16	13.90	13.90	0.00	0.00	6.95	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	6240.78	15.02	22.52	22.02	20.27	7.26	5.01	7.51
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6704.31	21.41	15.83	12.10	3.72	3.72	1.86	7.91
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	5100.13	58.40	58.40	19.47	0.00	0.00	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6309.03	19.31	24.59	28.25	11.99	7.32	5.89	9.75
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6501.31	26.93	16.63	7.13	4.75	5.54	5.15	5.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	4138.91	25.65	17.10	0.00	0.00	0.00	17.10	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	6794.55	19.47	27.43	23.01	16.81	14.16	12.39	5.31
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7434.23	14.82	18.62	14.82	8.74	14.44	3.42	7.98
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5462.33	30.27	13.16	21.05	3.95	1.32	1.32	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	6421.07	12.95	13.79	19.10	18.25	6.15	8.28	6.58
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4865.64	14.73	14.73	4.60	0.92	4.60	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	646.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	6133.10	19.08	28.61	26.53	13.41	6.56	7.45	9.24
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	4354.33	35.21	6.71	3.35	0.00	1.68	3.35	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	4039.97	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6076.37	13.05	19.07	24.34	17.81	9.03	10.29	9.53
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5867.54	18.30	17.11	10.22	4.28	7.13	1.66	4.75
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6070.10	26.54	8.85	27.09	2.21	0.00	12.72	3.87
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6009.65	13.35	22.10	24.87	11.28	8.98	4.60	5.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6286.62	25.87	18.72	7.78	9.68	7.99	2.94	5.89
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	6373.30	17.73	11.21	4.48	11.41	5.50	2.24	4.69
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	5789.12	14.37	21.02	22.96	9.65	6.44	3.86	5.79
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5982.96	29.56	18.89	9.78	3.78	5.33	3.33	3.56
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	5344.98	10.32	10.32	10.32	0.00	0.00	10.32	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5394.60	14.46	21.46	23.00	5.69	7.01	6.13	5.91
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5747.87	30.42	16.73	14.70	2.03	4.56	1.52	6.08
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	5534.37	31.48	14.91	9.94	1.66	0.00	6.63	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6758.92	21.74	25.55	30.98	12.23	5.98	10.87	7.34
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6607.16	22.64	18.23	10.29	5.00	4.12	4.12	5.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6351.14	80.68	44.70	16.35	2.18	3.27	11.99	7.63
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8254.48	21.62	30.76	19.70	7.69	18.26	9.13	4.81
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6209.95	40.82	28.42	10.81	8.00	8.00	7.20	7.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5479.38	21.94	12.34	58.96	2.74	5.48	13.71	5.48
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	10923.60	31.54	49.56	24.03	10.51	15.52	6.01	14.02
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	2775.56	0.00	53.89	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4969.86	36.69	8.15	10.19	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9687.27	35.91	42.48	33.28	13.58	13.14	9.20	7.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4207.13	28.69	9.93	69.53	2.21	1.10	7.73	7.73
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	6830.38	30.74	9.61	9.61	3.84	1.28	1.28	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10006.01	31.24	29.75	28.26	13.88	13.14	8.93	7.69
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4155.20	27.84	6.96	27.14	2.78	2.78	5.57	5.57
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8150.01	50.83	24.31	15.47	2.21	2.21	4.42	6.63
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	10708.25	32.48	37.61	38.29	14.70	15.04	8.89	11.97
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5243.06	24.94	9.19	14.44	5.69	2.19	3.06	4.38
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9460.11	41.19	7.81	20.95	6.39	2.49	7.46	5.68
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12299.10	41.24	47.13	55.83	20.48	22.72	10.66	15.15
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4758.53	24.11	8.31	13.30	5.82	1.66	2.08	2.49
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6822.21	32.05	12.24	14.57	6.99	5.24	1.17	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12450.92	47.66	57.32	48.27	17.80	16.89	13.88	14.78
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5187.34	29.63	19.20	20.45	6.68	4.59	7.10	6.68
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	6258.72	50.53	14.44	14.44	0.00	0.00	7.22	14.44
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10341.04	43.41	28.63	42.48	18.47	8.31	7.39	5.54
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5633.70	39.27	21.63	21.06	3.98	3.98	6.26	7.97
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7862.38	26.12	10.92	6.63	26.67	3.59	2.35	4.84
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8452.39	30.84	34.21	30.32	12.18	12.96	8.03	8.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	4843.57	24.45	15.01	12.01	3.00	5.58	4.72	2.57
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4890.34	33.03	6.35	5.72	3.81	3.81	0.64	2.54
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7232.43	29.62	22.95	26.69	6.67	7.47	6.14	6.94
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	4207.37	17.66	10.18	9.58	5.09	4.19	5.39	2.69
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5166.22	17.80	9.04	3.11	10.88	2.97	1.13	2.68
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	6867.79	22.93	28.35	27.07	7.64	14.33	6.37	7.01
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	4462.86	19.02	12.83	9.29	6.86	4.42	3.10	3.98
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	5457.45	27.30	5.69	3.03	3.79	2.65	0.76	1.90
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6298.63	26.42	33.24	22.73	10.51	7.10	6.25	5.68
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	5008.25	24.09	14.99	10.57	12.78	6.88	4.92	5.90
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3620.68	13.03	5.87	13.69	1.96	2.61	4.56	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5175.47	21.17	20.29	29.70	11.76	8.23	5.00	6.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4289.72	20.18	14.70	8.07	8.36	4.04	2.02	4.04
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	5050.82	14.43	14.43	9.48	5.77	4.12	7.83	3.30
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	4309.51	11.32	13.10	9.23	5.06	2.98	3.28	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	4105.89	11.30	18.83	11.30	0.00	11.30	30.14	15.07
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	4179.38	12.48	14.26	19.60	3.56	10.69	3.56	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	7010.41	9.86	14.13	19.06	17.41	14.13	13.80	3.61
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	7672.94	14.73	25.25	29.45	14.73	25.25	16.83	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4609.46	7.12	13.64	8.70	2.37	6.13	6.52	2.97
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	4317.61	13.04	20.49	10.24	5.59	2.79	3.73	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	5365.19	15.40	22.91	24.03	10.89	16.15	14.65	5.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	6588.52	19.71	17.05	20.77	8.52	8.52	11.19	5.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	4717.90	4.98	9.50	9.61	2.94	3.51	1.13	2.15
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5881.27	7.37	12.52	5.89	4.42	5.89	6.63	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6155.93	12.82	27.12	12.82	11.36	16.49	6.23	7.69
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6881.96	35.78	59.11	49.78	7.78	56.00	20.22	9.33
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	4645.87	5.88	8.02	5.34	0.53	2.67	1.60	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	6019.96	7.73	38.64	0.00	3.86	11.59	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	7876.52	11.11	35.35	23.23	8.08	24.24	12.12	6.06
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5653.76	8.01	16.87	19.40	5.90	8.43	9.28	4.22
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	3107.95	1.36	8.17	1.36	0.00	1.36	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4562.47	4.45	5.09	1.91	0.64	2.54	2.54	1.91
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4625.79	6.48	4.05	6.48	0.81	3.24	0.81	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	2776.18	10.57	12.08	13.59	3.02	9.06	13.59	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	3123.46	5.71	0.00	5.71	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3888.84	13.05	3.26	13.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4220.20	9.50	19.01	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	1920.01	37.65	25.10	25.10	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	4977.00	52.78	6.25	10.99	6.68	5.39	1.29	2.37
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	4281.76	28.74	13.07	7.84	11.50	4.70	8.36	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	5557.50	44.72	24.03	7.34	5.34	7.34	4.67	2.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	4927.06	46.75	20.45	15.44	2.92	14.19	2.50	4.17
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	3530.36	30.04	12.74	10.08	19.96	47.73	3.42	4.56
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	4174.75	23.94	9.58	15.96	0.00	0.00	11.17	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	3317.45	31.96	17.00	10.20	6.80	6.80	1.36	4.08
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1567.51	18.38	7.35	1.84	1.84	53.29	5.51	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3583.49	26.79	18.83	8.37	12.14	11.72	4.19	5.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	3980.51	31.61	13.48	5.58	7.90	11.16	4.18	2.79
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4560.08	34.05	23.78	8.65	18.11	11.35	4.59	8.38
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	3202.33	19.13	9.67	13.24	1.68	2.10	2.73	2.52
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1703.61	0.00	22.27	0.00	0.00	44.54	33.40	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4582.86	30.77	20.85	6.45	12.91	18.86	5.96	3.97
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	2243.04	8.93	8.93	3.25	5.68	41.41	5.68	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	3410.88	26.30	22.44	6.57	15.87	17.91	5.89	3.63
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	3349.15	17.80	8.98	4.41	5.23	5.23	2.12	1.63
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	3167.41	12.39	9.84	8.93	8.02	5.47	3.83	2.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	3613.33	24.40	19.63	5.83	11.67	14.85	3.18	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4005.84	24.61	22.81	6.60	6.60	12.01	2.40	5.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	1983.50	12.47	7.22	9.52	8.20	57.76	2.63	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3286.46	22.44	12.03	4.23	14.96	14.31	3.58	4.07
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	3283.00	15.70	7.76	11.46	4.76	2.29	3.70	3.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	3305.19	23.91	25.32	11.25	7.74	12.66	3.52	8.44
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	3280.48	19.77	18.85	8.27	12.87	14.25	4.14	4.60
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	3802.47	17.03	22.17	6.75	17.03	15.10	6.11	3.53
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	2424.22	25.87	15.18	11.04	13.80	165.89	5.17	3.79
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2012.64	17.70	5.06	12.64	10.11	75.85	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	2938.97	15.82	4.68	9.80	3.56	1.78	3.56	2.01
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	2553.48	23.71	10.58	11.01	9.74	18.21	6.35	2.54
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	2195.50	14.48	6.41	5.22	7.60	12.34	3.09	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	4103.19	14.59	21.03	5.58	25.75	12.45	3.43	3.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	947.91	0.00	9.03	18.06	18.06	63.19	18.06	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	3423.19	20.66	15.33	4.67	6.33	8.33	1.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	2572.17	12.62	5.86	10.37	0.00	0.45	2.71	2.71
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	2484.76	22.62	16.27	3.97	6.35	8.73	5.95	2.78
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	3378.41	24.14	26.93	3.71	10.22	12.07	1.86	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	2693.63	8.70	10.97	3.41	10.59	18.92	7.19	3.41
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	2970.77	29.98	19.88	8.47	6.19	11.41	1.30	5.21
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	2595.10	16.56	10.46	2.18	4.36	6.10	0.44	1.74
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	3614.22	18.54	13.12	20.81	2.26	3.17	4.52	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	3219.85	23.81	14.11	7.06	9.70	7.94	1.76	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	2981.17	21.28	18.62	7.31	7.98	15.96	4.65	5.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	3795.73	19.35	22.82	13.39	15.38	4.96	3.47	7.44
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	2926.32	15.70	14.55	5.36	6.89	10.72	0.77	3.45
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	2145.25	12.10	7.26	2.42	5.14	9.07	4.23	2.72
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	3461.01	17.68	12.60	13.92	3.32	2.21	2.21	2.65
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2810.92	19.65	8.81	4.07	11.52	6.78	4.74	2.71
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	863.51	5.11	0.00	0.00	0.00	20.44	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3127.67	18.29	13.41	3.66	12.19	10.36	2.44	5.49
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	2577.05	21.40	7.24	6.61	5.67	12.27	1.89	3.15
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	1696.07	14.53	8.17	5.75	4.84	8.47	0.00	3.03
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5113.13	34.81	35.60	15.82	18.99	22.15	9.49	7.91
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	1921.53	12.47	9.07	18.14	9.07	129.24	2.27	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	753.63	5.06	5.06	10.12	0.00	30.35	15.17	0.00
Myoblast, donor1	11241-116D8	5563.07	48.57	16.15	12.42	8.94	8.70	2.36	6.96
Myoblast, donor2	11322-117D8	3814.67	27.81	8.44	3.84	11.12	4.41	3.45	2.69
Myoblast, donor3	11398-118D3	5553.41	34.81	12.11	4.54	5.21	5.72	2.86	4.20
NK T cell leukemia cell line:KHYG-1	10777-110G3	4596.15	18.68	11.82	15.47	4.96	5.11	3.94	4.23
Natural Killer Cells, donor1	11230-116C6	5209.03	26.14	10.76	13.84	8.92	8.30	4.61	5.54
Natural Killer Cells, donor2	11311-117C6	4497.41	23.82	10.55	9.35	13.87	6.94	9.35	8.44
Natural Killer Cells, donor3	11387-118C1	4474.90	24.85	11.41	17.67	9.02	6.81	6.81	4.05
Neural stem cells, donor1	11275-116H6	6119.16	26.49	3.99	4.72	3.99	5.44	10.53	2.18
Neural stem cells, donor2	11352-117H2	6976.61	28.88	7.70	9.63	1.93	3.85	5.78	1.93
Neurons, donor1	11494-119E9	8206.52	34.14	13.65	5.69	5.69	14.79	17.07	3.41
Neurons, donor2	11574-120E8	6935.58	19.59	11.67	11.45	5.94	7.05	5.50	3.52
Neurons, donor3	11655-122E8	6518.95	50.15	52.62	23.84	13.15	20.55	44.40	13.98
Neutrophils, donor1	11233-116C9	14195.69	36.19	19.49	33.41	33.41	64.96	19.49	5.57
Neutrophils, donor2	11314-117C9	14369.73	89.87	69.57	37.69	46.38	113.06	69.57	43.48
Neutrophils, donor3	11390-118C4	20346.55	35.43	38.48	40.93	70.86	62.92	20.77	12.83
Nucleus Pulposus Cell, donor1	11252-116F1	3049.13	16.86	4.99	4.51	3.92	2.85	0.83	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	2094.93	15.95	8.79	3.26	0.33	4.23	4.56	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	2460.98	8.02	5.01	2.41	5.01	4.21	4.81	3.01
Olfactory epithelial cells, donor1	11933-125I7	6020.20	20.23	33.59	21.61	11.01	16.38	15.55	11.56
Olfactory epithelial cells, donor2	11934-125I8	6525.70	30.11	33.15	22.58	18.67	26.49	26.78	17.51
Olfactory epithelial cells, donor3	11935-125I9	6008.61	16.57	21.11	16.69	7.95	10.90	11.01	7.95
Olfactory epithelial cells, donor4	11936-126A1	7235.45	18.12	25.91	15.49	9.64	10.13	6.53	7.21
Oligodendrocyte - precursors, donor1	11496-119F2	8658.38	24.07	12.04	13.24	7.82	6.02	1.20	3.01
Osteoblast - differentiated, donor1	11276-116H7	4910.90	36.80	7.87	5.10	13.40	3.19	1.70	2.77
Osteoblast - differentiated, donor2	11353-117H3	2010.74	37.72	14.86	4.57	6.86	4.57	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	1641.78	7.45	3.72	2.48	4.34	1.86	1.24	1.86
Osteoblast, donor1	11277-116H8	12969.79	67.23	22.08	12.12	10.75	6.25	2.93	8.40
Osteoblast, donor2	11354-117H4	8576.70	31.60	8.43	8.43	0.70	7.02	1.40	2.11
Osteoblast, donor3	11426-118G4	8713.94	43.19	17.60	6.22	17.24	6.40	2.49	3.73
Pancreatic stromal cells, donor1	11249-116E7	6059.48	26.11	9.43	15.50	13.06	10.61	5.22	4.46
Pericytes, donor1	11491-119E6	4707.23	22.59	6.34	3.23	6.12	3.00	1.89	2.11
Pericytes, donor2	11571-120E5	3040.55	21.50	4.75	1.58	8.83	4.30	3.40	1.81
Pericytes, donor3	11652-122E5	8643.57	33.77	17.09	7.93	14.44	13.22	5.90	6.10
Perineurial Cells, donor1	11499-119F5	4920.61	19.10	7.12	7.12	3.84	5.20	2.37	2.15
Perineurial Cells, donor2	11579-120F4	4624.10	21.90	6.53	3.96	3.40	4.78	1.75	2.48
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	6822.94	16.89	12.43	10.20	6.37	5.74	2.87	4.46
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	5453.57	18.36	15.92	8.57	11.51	6.37	6.61	6.61
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	5834.84	18.38	11.52	10.22	11.00	6.60	3.62	3.62
Placental Epithelial Cells, donor1	11278-116H9	4445.87	7.17	5.74	6.22	5.74	5.50	4.54	3.11
Placental Epithelial Cells, donor2	11355-117H5	3838.96	6.65	2.22	5.54	2.22	7.76	4.44	1.11
Placental Epithelial Cells, donor3	11427-118G5	4281.31	11.58	7.85	2.55	6.09	6.87	4.71	3.34
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8198.01	47.78	46.83	17.72	29.11	49.68	7.59	12.03
Preadipocyte - breast, donor1	11467-119B9	5261.64	30.39	12.01	3.94	6.38	4.50	3.94	3.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9434.65	31.20	19.19	13.44	8.75	7.18	4.70	7.44
Preadipocyte - breast, donor2	11328-117E5	6764.59	31.75	18.46	8.11	20.04	8.56	11.26	10.58
Preadipocyte - omental, donor1	11468-119C1	4668.97	29.84	10.23	7.25	10.34	6.82	4.16	3.73
Preadipocyte - omental, donor2	11329-117E6	8072.52	35.35	17.02	13.09	6.11	6.55	7.86	5.24
Preadipocyte - omental, donor3	11403-118D8	10311.46	53.72	31.08	32.66	29.65	14.90	12.89	17.19
Preadipocyte - perirenal, donor1	11469-119C2	7526.70	24.61	13.78	3.94	17.72	13.78	8.86	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	12059.89	51.90	8.91	3.99	11.67	2.46	3.07	2.76
Preadipocyte - subcutaneous, donor2	11356-117H6	8216.21	27.98	10.27	6.73	16.65	9.39	6.73	9.21
Preadipocyte - subcutaneous, donor3	11428-118G6	6096.87	26.39	8.00	6.98	10.73	14.13	11.07	4.77
Preadipocyte - visceral, donor1	11280-116I2	6542.67	29.34	4.56	6.33	5.59	6.05	3.35	3.07
Preadipocyte - visceral, donor2	11357-117H7	4973.63	29.91	8.74	5.52	9.20	7.36	9.20	1.84
Preadipocyte - visceral, donor3	11429-118G7	5972.27	23.72	12.23	9.93	18.70	13.06	14.11	8.15
Prostate Epithelial Cells (polarized), donor1	11253-116F2	4382.71	26.25	7.39	11.62	25.95	14.78	4.68	2.87
Prostate Epithelial Cells, donor2	11331-117E8	4753.42	34.40	9.07	8.94	17.87	13.27	12.73	6.91
Prostate Epithelial Cells, donor3	11404-118D9	3657.34	16.78	8.08	13.78	14.51	10.23	7.29	4.16
Prostate Stromal Cells, donor1	11254-116F3	6349.72	32.01	14.35	14.81	10.82	9.68	3.53	6.38
Prostate Stromal Cells, donor2	11332-117E9	5884.94	28.15	8.96	6.63	8.79	10.22	8.07	8.25
Prostate Stromal Cells, donor3	11405-118E1	4050.39	26.90	8.45	13.45	11.68	13.56	5.94	6.67
Renal Cortical Epithelial Cells, donor1	11516-119H4	9580.06	28.83	17.15	16.06	6.20	2.19	1.09	4.38
Renal Cortical Epithelial Cells, donor2	11596-120H3	6008.29	22.04	11.23	7.14	4.09	5.89	1.80	3.05
Renal Epithelial Cells, donor1	11517-119H5	15028.24	47.17	20.29	9.64	5.07	7.61	2.54	5.07
Renal Epithelial Cells, donor2	11597-120H4	8953.39	38.41	14.94	12.80	4.27	9.96	2.13	3.56
Renal Epithelial Cells, donor3	11678-122H4	5953.31	26.04	8.15	5.40	4.13	4.34	1.80	3.07
Renal Glomerular Endothelial Cells, donor1	11514-119H2	5922.05	27.23	14.30	7.49	21.11	7.49	6.81	4.77
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5509.97	31.27	19.54	5.66	18.73	9.43	9.43	7.01
Renal Glomerular Endothelial Cells, donor3	11675-122H1	6397.02	40.41	18.43	10.43	11.10	11.99	3.55	6.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7772.38	30.61	29.94	8.65	6.65	5.99	4.66	6.65
Renal Mesangial Cells, donor1	11518-119H6	9887.24	44.68	16.73	12.10	7.04	6.60	3.30	5.50
Renal Mesangial Cells, donor2	11598-120H5	9804.16	34.48	12.54	10.03	10.03	6.90	5.02	6.90
Renal Mesangial Cells, donor3	11679-122H5	8709.05	34.95	12.21	8.32	14.43	9.99	5.83	5.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8551.67	27.92	20.94	13.42	2.68	4.03	2.95	6.71
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5965.68	22.35	14.34	11.81	10.54	6.33	7.17	2.95
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	9069.02	32.98	18.13	11.19	14.08	9.45	4.63	8.29
Retinal Pigment Epithelial Cells, donor0	11215-116A9	3878.34	22.56	6.74	7.26	3.37	6.48	3.37	2.59
Retinal Pigment Epithelial Cells, donor1	11528-119I7	5693.13	21.03	11.37	7.96	3.98	4.55	1.42	1.99
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6379.54	25.73	15.44	7.20	0.00	6.17	1.03	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	2440.33	11.79	4.52	0.50	1.76	2.01	0.50	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	2416.67	8.42	5.48	7.08	11.89	4.94	2.00	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	1190.91	16.08	1.79	8.93	1.79	2.68	0.00	4.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1665.97	18.71	4.95	11.01	3.30	4.40	2.20	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	1106.16	15.66	2.90	2.32	1.74	0.58	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	3866.17	12.22	4.55	3.51	5.07	1.82	2.47	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	4168.45	17.38	9.43	2.98	9.43	3.77	3.57	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	3906.88	16.40	5.47	3.35	2.45	2.79	1.12	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	4272.17	13.64	7.19	3.72	8.68	3.97	6.45	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	4893.26	17.71	12.82	4.43	11.30	4.66	4.66	5.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	4224.86	22.19	11.33	5.55	6.47	3.70	4.39	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	3141.51	13.28	5.34	1.92	6.02	2.74	4.52	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	4529.12	18.15	8.32	3.63	10.29	3.93	3.93	6.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	4036.08	16.13	6.45	3.76	1.25	2.15	2.15	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	3431.48	11.91	4.59	2.30	4.45	5.45	7.89	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	4413.20	18.67	7.73	4.08	11.91	2.90	4.29	3.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	4199.92	18.81	10.62	4.65	7.52	3.76	4.43	3.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	2899.95	12.81	5.54	1.91	4.78	1.91	1.34	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	4301.89	16.96	8.20	4.38	9.04	2.52	2.61	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	4093.93	14.47	3.38	2.82	3.19	2.25	2.25	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	3860.84	10.09	7.43	2.92	6.24	2.79	3.85	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	4159.09	14.80	5.55	3.21	6.62	2.43	1.56	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	4170.73	17.57	7.26	4.39	3.25	4.20	5.92	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	3749.30	11.64	5.66	2.99	6.83	2.03	4.49	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	4210.75	23.83	12.33	3.92	5.89	7.29	3.36	3.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	4021.58	17.94	7.69	2.22	5.30	3.76	2.22	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	3636.21	12.76	5.83	2.01	4.56	2.73	4.01	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	4405.20	18.03	8.95	3.80	7.85	3.68	4.05	5.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	4298.91	18.40	7.92	4.70	5.78	2.82	2.69	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	3545.64	12.74	8.26	3.54	2.59	4.01	8.73	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	4636.72	17.06	8.93	6.35	12.10	5.16	3.97	5.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	4234.02	18.24	9.82	3.74	7.72	5.61	6.08	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	3586.83	12.86	3.53	2.49	5.81	4.77	4.35	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	4056.55	24.55	9.73	2.88	9.29	4.65	4.87	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	4341.45	16.50	10.86	3.97	7.31	2.30	2.92	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	4033.77	14.27	4.58	3.63	5.38	3.63	5.52	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	4290.58	17.71	5.28	4.26	6.13	2.72	2.21	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	4193.67	17.93	11.57	7.71	8.10	2.51	3.08	4.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	3672.41	16.51	4.13	2.92	3.61	4.13	8.25	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	4506.68	16.87	11.11	5.08	6.04	3.15	3.15	2.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	4212.09	20.03	10.84	6.24	7.22	4.93	6.90	5.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	2931.41	15.34	5.28	2.05	3.24	3.41	3.41	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	4899.32	16.72	7.84	5.47	8.14	4.88	2.66	3.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	4062.77	17.59	9.33	5.86	2.93	1.87	2.40	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	1684.78	14.38	2.77	1.11	3.04	1.38	2.35	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	3200.57	17.38	7.14	3.33	7.14	4.29	3.57	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	3615.25	24.39	4.23	2.82	7.46	1.81	2.02	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	2672.76	12.62	2.83	2.64	6.31	1.60	7.16	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	2272.95	15.72	2.79	2.10	5.59	2.10	3.84	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	1838.06	19.34	5.14	3.02	5.44	3.02	1.81	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	3221.95	18.11	1.84	3.06	12.12	3.06	15.67	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	1814.46	16.30	3.49	1.75	1.60	1.46	0.73	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	2291.95	14.60	7.30	2.43	6.08	4.87	4.26	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	2739.11	15.07	3.62	2.41	7.84	5.12	12.06	2.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	2369.10	18.77	3.85	4.75	10.86	13.57	8.60	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	2142.61	25.46	4.19	3.00	5.39	2.40	6.29	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	2073.86	12.16	3.07	2.60	10.15	2.48	4.01	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	2202.54	27.96	12.17	10.67	20.49	19.42	3.20	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	1665.91	32.45	8.41	7.81	6.61	3.00	0.60	3.61
Schwann Cells, donor1	11498-119F4	10751.84	35.55	20.12	7.71	27.83	12.22	11.10	11.47
Schwann Cells, donor2	11578-120F3	5300.96	30.62	10.21	3.40	0.00	10.21	0.00	10.21
Schwann Cells, donor3	11659-122F3	7404.94	39.43	25.41	17.09	7.23	11.61	8.76	7.89
Sebocyte, donor1	11220-116B5	13375.98	24.10	13.69	5.48	21.36	4.38	0.00	7.12
Sebocyte, donor2	11301-117B5	6800.95	22.98	9.19	7.81	14.25	7.35	2.30	6.43
Sebocyte, donor3	11378-118B1	5647.28	25.76	11.75	4.95	11.54	5.15	3.30	5.36
Sertoli Cells, donor1	11255-116F4	8665.66	29.82	18.22	33.13	9.94	18.22	8.28	3.31
Sertoli Cells, donor2	11333-117F1	3533.28	19.77	25.42	14.12	2.82	8.47	5.65	5.65
Skeletal Muscle Cells, donor1	11281-116I3	3550.17	15.48	4.93	4.84	4.93	6.69	2.90	1.58
Skeletal Muscle Cells, donor2	11358-117H8	1997.94	14.46	3.61	1.45	9.40	2.17	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	16732.47	54.34	32.61	9.20	40.13	20.90	4.18	10.87
Skeletal Muscle Cells, donor4	11451-119A2	4484.24	21.21	13.82	5.66	14.77	9.74	8.95	5.97
Skeletal Muscle Cells, donor5	11455-119A6	4462.46	22.59	12.63	6.39	16.35	5.95	6.39	4.16
Skeletal Muscle Cells, donor6	11459-119B1	5054.31	19.39	11.85	6.93	14.77	7.70	8.16	5.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	6070.60	21.55	11.21	11.84	10.96	5.54	3.28	4.79
Skeletal Muscle Satellite Cells, donor2	11321-117D7	5718.96	21.55	11.84	5.42	10.13	6.99	3.57	4.99
Skeletal Muscle Satellite Cells, donor3	11397-118D2	5644.85	26.39	14.39	8.63	8.43	7.04	3.87	5.36
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	4260.87	20.73	5.64	3.62	5.81	3.62	2.11	2.86
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	8301.57	48.49	37.64	7.24	13.75	2.17	5.07	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5914.96	38.39	17.20	8.81	25.87	8.39	7.29	7.16
Skin - palm, donor1	10286-104F7	1402.15	21.49	2.69	5.37	0.00	0.00	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4446.94	22.34	19.32	7.06	14.13	16.72	2.31	3.75
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	2087.26	14.72	4.91	2.45	0.82	3.27	1.64	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5701.76	25.32	28.17	7.92	13.63	17.14	2.34	5.84
Small Airway Epithelial Cells, donor1	11256-116F5	4083.64	20.57	10.01	10.98	6.95	8.20	2.50	4.31
Small Airway Epithelial Cells, donor2	11334-117F2	3739.37	18.85	12.24	11.25	13.08	2.81	4.08	5.20
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	3194.52	11.00	11.63	4.65	1.48	2.75	1.27	3.17
Small Airway Epithelial Cells, donor3	11406-118E2	2759.90	17.76	13.04	10.87	6.22	2.77	1.95	3.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4103.24	28.08	6.79	4.32	4.32	14.50	10.49	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	3573.75	16.23	4.00	2.22	7.34	2.45	5.34	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8036.77	41.74	12.93	9.41	4.70	7.64	1.18	5.29
Smooth Muscle Cells - Aortic, donor1	11283-116I5	11377.08	23.43	4.20	4.86	4.42	2.43	1.99	2.43
Smooth Muscle Cells - Aortic, donor2	11360-117I1	10207.57	66.55	16.93	12.21	8.27	8.27	3.15	5.51
Smooth Muscle Cells - Aortic, donor3	11432-118H1	8037.79	41.72	7.73	10.04	4.64	2.32	6.18	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	2399.81	18.01	8.01	5.00	3.00	4.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13317.61	64.68	22.09	10.78	23.42	7.05	3.99	6.39
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	3973.82	17.29	7.54	7.31	8.87	8.20	5.98	3.32
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	3166.06	26.50	7.30	1.79	12.68	1.79	1.41	3.33
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	5235.49	36.47	14.00	15.30	3.26	5.54	2.93	4.56
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	6317.60	36.03	17.72	7.97	2.95	8.86	3.25	3.84
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	6355.85	30.89	14.81	9.54	9.82	6.98	5.13	5.55
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	9534.85	28.63	10.90	10.25	6.67	3.09	2.11	5.37
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	3244.34	18.27	4.87	3.65	6.09	3.65	1.52	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	5775.87	26.52	3.54	3.03	7.07	1.26	2.02	2.27
Smooth Muscle Cells - Carotid, donor2	11362-117I3	3623.46	42.84	0.00	0.00	18.36	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9855.74	40.05	23.84	10.01	28.61	10.49	5.72	6.68
Smooth Muscle Cells - Colonic, donor1	11239-116D6	5787.32	20.79	15.63	15.04	5.75	9.73	3.98	5.75
Smooth Muscle Cells - Colonic, donor2	11320-117D6	4964.05	22.82	12.27	6.67	10.12	4.95	4.52	4.74
Smooth Muscle Cells - Colonic, donor3	11396-118D1	5819.92	26.24	18.47	10.92	12.49	6.82	4.09	5.14
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12101.76	73.94	16.55	14.39	17.63	5.41	7.73	6.50
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8807.33	87.31	35.57	7.55	14.01	10.78	7.55	7.55
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	6484.28	23.91	20.62	7.77	20.32	4.48	7.47	5.08
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	12335.10	39.26	20.48	14.68	6.83	9.22	4.10	8.19
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	4317.69	9.19	6.20	3.85	2.83	5.42	1.88	2.12
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	4532.27	47.10	5.64	12.98	17.71	16.40	4.73	3.02
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	3978.08	19.57	4.78	4.32	7.05	7.05	5.69	2.50
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9514.86	42.87	22.34	1.81	18.11	7.25	7.25	7.25
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	5761.34	40.53	10.60	12.45	2.38	9.54	2.38	6.62
Smooth Muscle Cells - Prostate, donor1	11257-116F6	6042.50	20.64	11.98	9.85	9.85	6.26	9.99	4.26
Smooth Muscle Cells - Prostate, donor2	11335-117F3	4137.76	27.05	7.51	11.39	13.90	9.52	9.52	3.76
Smooth Muscle Cells - Prostate, donor3	11465-119B7	3992.90	17.76	10.15	6.34	3.55	4.82	3.55	1.78
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	7947.40	59.40	13.27	5.43	15.83	6.03	3.62	3.47
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	4585.77	27.76	10.50	4.50	6.75	3.75	3.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	55688.00	43.94	9.05	5.17	50.40	1.29	11.63	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11105.88	48.37	18.14	6.05	10.23	6.05	2.79	4.65
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	5945.49	38.37	9.59	6.06	10.10	8.08	13.13	4.54
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6503.87	41.68	13.79	9.72	26.64	5.33	6.89	8.15
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4917.64	29.20	13.27	5.01	2.65	3.83	1.77	3.83
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	6320.65	27.16	21.74	28.24	2.92	4.67	3.25	10.41
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	4191.35	19.62	10.74	8.88	3.27	5.14	1.87	4.67
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	13144.34	61.74	17.85	12.23	14.68	7.48	5.18	7.05
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	14991.39	67.82	44.62	29.32	35.95	13.00	7.14	14.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	10032.89	44.75	25.38	13.91	30.09	9.03	8.09	7.52
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	7046.75	22.22	11.46	12.44	4.33	7.83	2.10	3.49
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	8961.98	19.19	14.75	12.90	9.80	8.21	1.59	5.53
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4110.88	8.10	8.57	5.24	1.43	4.29	5.24	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	12321.90	61.17	20.80	11.01	19.57	7.58	3.43	7.58
Smooth Muscle Cells - Uterine, donor1	11258-116F7	8944.65	25.85	12.37	12.59	17.90	11.27	22.76	5.08
Smooth Muscle Cells - Uterine, donor3	11466-119B8	5136.22	21.07	7.31	6.44	1.17	5.85	7.02	1.76
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	2263.91	10.50	3.30	5.44	5.64	5.25	1.75	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	3972.35	37.82	12.16	18.78	4.23	13.75	2.38	6.35
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2845.02	22.32	6.70	20.46	8.18	15.99	5.95	6.70
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	4997.66	41.32	11.50	14.73	8.26	10.78	2.87	4.31
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4142.38	44.86	8.80	12.49	4.26	4.83	0.00	1.99
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	6563.43	29.54	15.36	27.57	9.45	13.00	3.94	5.12
Smooth muscle cells - airway, control, donor1	11966-126D4	2262.96	20.82	5.33	13.21	8.63	11.68	2.29	3.30
Smooth muscle cells - airway, control, donor2	11967-126D5	2506.13	15.97	7.99	13.18	5.59	13.18	3.99	2.40
Smooth muscle cells - airway, control, donor3	11968-126D6	3091.15	18.39	8.78	16.72	5.85	24.24	6.69	4.18
Smooth muscle cells - airway, control, donor4	11969-126D7	2161.17	13.75	4.13	11.00	2.29	6.42	1.38	0.46
Synoviocyte, donor1	11291-117A4	9850.47	21.88	18.52	12.62	8.42	16.16	12.46	4.54
Synoviocyte, donor2	11368-117I9	2922.36	12.91	6.87	6.70	6.87	8.05	6.37	3.02
Synoviocyte, donor3	11440-118H9	2060.95	5.36	4.92	2.46	5.81	5.14	9.61	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	9236.65	47.53	11.08	7.86	4.65	3.22	1.07	3.57
Trabecular Meshwork Cells, donor2	11612-122A1	3171.26	9.91	7.93	1.98	0.00	1.98	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	7364.35	29.17	9.03	7.18	9.49	6.25	3.01	3.47
Tracheal Epithelial Cells, donor1	11292-117A5	6776.39	23.01	22.58	13.91	8.53	5.16	3.44	8.17
Tracheal Epithelial Cells, donor2	11369-118A1	7894.77	20.10	18.56	10.82	13.53	6.19	0.77	5.80
Tracheal Epithelial Cells, donor3	11441-118I1	6716.76	20.04	15.46	3.44	33.21	3.44	4.58	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	2481.40	9.10	4.92	7.63	11.44	4.92	1.11	2.09
Urethra, donor2	10319-105A4	3165.23	10.79	5.40	5.40	0.00	1.80	16.19	1.80
Urothelial Cells, donor1	11520-119H8	8983.33	20.99	15.94	9.83	7.17	6.38	2.13	5.58
Urothelial Cells, donor2	11600-120H7	6303.69	19.63	15.22	13.62	9.21	6.41	5.61	5.61
Urothelial Cells, donor3	11681-122H7	6073.25	11.92	11.69	6.19	9.17	7.79	2.98	2.52
Urothelial cells, donor0	11216-116B1	8996.27	18.72	17.39	14.49	7.36	7.13	3.12	6.91
Whole blood (ribopure), donor090309, donation1	12179-129A1	13950.91	31.14	25.80	8.90	2.67	8.90	5.34	11.57
Whole blood (ribopure), donor090309, donation2	12180-129A2	13319.69	27.16	15.73	8.58	7.15	10.01	7.15	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	9211.58	26.01	15.74	4.11	12.32	6.16	6.16	10.95
Whole blood (ribopure), donor090325, donation1	12176-128I7	8801.27	13.77	16.53	9.99	3.44	7.58	3.79	7.23
Whole blood (ribopure), donor090325, donation2	12177-128I8	9159.90	23.82	18.59	10.46	2.91	9.88	2.32	5.81
Whole blood (ribopure), donor090612, donation1	12182-129A4	11503.63	14.58	16.66	5.21	4.16	4.16	6.25	9.37
Whole blood (ribopure), donor090612, donation2	12183-129A5	10963.95	19.27	13.77	2.75	3.67	8.26	6.42	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	9401.03	21.00	31.04	11.87	12.78	10.95	9.13	4.56
Wilms' tumor cell line:G-401	10809-111A8	3935.10	27.39	17.15	11.72	6.04	5.18	3.45	4.19
Wilms' tumor cell line:HFWT	10597-108E3	1553.27	7.92	2.64	7.92	0.00	0.88	4.40	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	3749.56	19.55	10.33	11.73	3.63	3.91	2.51	3.35
achilles tendon, donor2	10292-104G4	1886.74	8.27	8.27	10.33	2.07	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	5868.58	17.34	22.18	36.71	2.80	9.69	8.92	9.43
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	4060.27	8.36	5.11	9.29	2.32	3.02	1.63	3.95
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	6204.63	20.18	11.75	8.19	5.10	4.04	3.09	3.68
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	7342.45	48.44	24.76	31.57	3.27	12.25	8.16	8.16
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	4461.64	13.49	13.77	7.59	4.50	5.62	3.09	4.50
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	3620.35	7.40	3.81	3.81	1.48	3.38	0.42	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	5920.33	17.42	15.24	16.88	4.63	8.71	2.72	7.62
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	2035.31	5.73	3.08	3.97	2.20	1.76	1.32	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	3698.92	13.48	9.39	6.13	2.45	4.08	2.45	2.45
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	5700.99	20.58	24.46	28.73	5.44	10.10	3.88	12.81
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	4022.24	13.98	8.10	4.97	4.42	3.86	2.94	3.68
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	2309.11	3.90	7.80	15.60	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	6309.63	19.98	18.36	8.37	6.27	6.74	5.34	4.65
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	6177.13	15.02	18.64	10.61	1.81	6.21	4.14	4.66
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	8211.47	20.75	24.26	14.90	7.31	10.52	4.38	7.31
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	5702.14	16.73	12.55	19.98	3.25	3.25	6.04	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	3957.90	10.69	13.16	11.10	3.70	2.88	3.29	2.88
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	6663.58	48.19	17.19	10.44	14.12	17.50	4.91	11.66
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	9347.91	38.83	7.25	10.24	8.96	4.69	2.99	2.99
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	10632.87	45.80	14.86	15.16	6.67	5.16	3.94	6.98
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	9970.51	44.05	10.35	13.72	8.18	4.57	2.41	6.74
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	7036.53	27.40	16.93	9.80	5.12	7.35	4.45	8.69
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	4309.76	23.35	21.35	12.67	1.67	2.67	3.00	3.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	2348.77	13.01	9.29	22.30	0.00	1.86	7.43	9.29
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	6720.38	28.63	17.70	10.92	5.65	4.14	3.39	6.40
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	4082.20	17.01	11.78	6.98	2.18	1.31	1.31	3.05
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	3537.11	35.61	11.25	35.61	0.00	5.62	5.62	15.00
adenocarcinoma cell line:IM95m	10796-110I4	2697.65	10.13	9.66	9.18	3.30	3.06	2.59	4.24
adipose tissue, adult, pool1	10010-101C1	5629.28	17.99	9.77	7.14	14.74	9.93	2.33	2.48
adipose, donor1	10184-103D4	3225.84	28.73	16.42	55.12	23.46	178.27	18.77	7.62
adipose, donor2	10185-103D5	2180.88	19.87	12.57	42.58	7.30	35.28	15.41	4.87
adipose, donor3	10186-103D6	2775.98	24.51	10.35	40.03	20.97	71.07	17.97	6.26
adipose, donor4	10187-103D7	2677.40	27.74	8.67	18.20	13.00	31.20	16.47	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	2969.23	57.60	9.63	10.73	2.84	2.37	2.05	2.53
adrenal gland, adult, pool1	10081-102A9	1666.05	7.28	0.00	3.64	3.64	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	4174.28	37.75	12.81	18.01	5.07	6.14	3.74	3.74
alveolar cell carcinoma cell line:SW 1573	10708-109H6	3347.54	22.15	11.08	9.65	5.72	6.43	3.57	5.36
amniotic membrane cells, donor1	12235-129G3	4340.92	9.74	12.06	8.35	6.72	10.43	3.48	5.80
amniotic membrane cells, donor2	12236-129G4	2476.27	5.07	4.40	7.10	6.42	3.38	1.69	0.68
amniotic membrane cells, donor3	12237-129G5	3706.97	5.01	10.02	6.78	7.66	2.36	4.42	3.24
amygdala - adult, donor10196	10167-103B5	2523.38	21.34	3.56	1.19	2.37	3.56	3.56	0.00
amygdala, adult, donor10252	10151-102I7	2159.07	12.17	4.06	4.06	4.66	2.23	3.24	2.43
amygdala, newborn, donor10223	10360-105E9	2014.40	66.49	5.16	11.30	2.58	4.52	1.29	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	2294.48	9.04	3.82	3.82	2.16	2.80	1.27	2.29
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	5208.03	21.18	25.15	25.15	8.16	13.90	5.29	7.94
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1708.27	9.02	2.67	9.02	1.00	5.34	2.00	1.34
aorta, adult, pool1	10052-101G7	7371.86	26.67	16.87	14.91	12.36	8.24	7.85	9.22
appendix, adult	10189-103D9	6517.28	28.33	10.09	13.20	21.35	14.75	7.37	7.76
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	2708.15	6.88	4.47	6.19	3.44	1.38	2.41	2.41
artery, adult	10190-103E1	2122.27	12.23	2.72	4.08	2.72	2.72	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	4334.14	16.37	14.92	12.75	3.48	4.06	3.19	6.37
b cell line:RPMI1788	10427-106D4	10090.57	23.20	13.98	9.96	7.58	5.06	2.68	6.10
basal cell carcinoma cell line:TE 354.T	10702-109G9	9158.53	71.30	29.41	17.48	9.71	14.43	8.32	9.43
bile duct carcinoma cell line:HuCCT1	10432-106D9	4627.37	21.33	8.63	6.65	5.46	3.47	1.79	2.48
bile duct carcinoma cell line:TFK-1	10496-107C1	2130.06	5.86	6.03	11.55	2.01	2.01	3.18	2.01
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	3022.12	6.15	11.18	9.51	4.47	6.15	2.80	3.91
bladder, adult, pool1	10011-101C2	9354.44	24.34	19.99	18.47	34.00	18.03	4.02	7.93
blood, adult, pool1	10053-101G8	8129.89	17.72	19.93	42.08	19.93	35.43	17.72	11.07
bone marrow stromal cell line:StromaNKtert	10686-109F2	6199.09	30.83	14.56	20.55	0.00	4.28	8.56	7.71
bone marrow, adult	10192-103E3	4401.89	18.22	6.75	4.72	5.40	4.72	4.72	0.00
brain, adult, donor1	10084-102B3	3274.07	29.73	5.13	8.20	9.23	8.20	5.13	5.13
brain, adult, pool1	10012-101C3	3932.39	25.17	5.23	8.24	8.24	6.01	1.56	3.45
brain, fetal, pool1	10085-102B4	5492.40	29.39	16.03	13.36	8.01	5.34	8.01	2.67
breast carcinoma cell line:MCF7	10482-107A5	2427.52	18.83	14.21	20.48	5.62	3.96	8.92	4.63
breast carcinoma cell line:MDA-MB-453	10419-106C5	3397.68	14.85	5.24	6.62	2.37	1.62	1.50	2.62
breast, adult, donor1	10080-102A8	3348.71	6.94	3.79	6.31	22.10	13.26	8.84	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	3024.26	6.86	8.64	6.48	3.30	4.07	3.30	2.79
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	2578.59	14.84	13.61	14.53	2.78	4.64	3.09	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	4524.50	29.70	11.05	11.05	6.45	13.58	5.53	3.45
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	2516.97	7.75	9.68	7.50	4.84	3.87	3.15	3.63
carcinoid cell line:NCI-H1770	10703-109H1	2264.80	15.99	7.05	9.40	3.76	5.64	2.82	0.94
carcinoid cell line:NCI-H727	10735-110B6	2239.02	5.69	4.38	4.92	2.95	1.09	0.44	1.97
carcinoid cell line:SK-PN-DW	10719-109I8	1879.83	15.84	12.04	8.56	2.22	4.75	2.85	2.85
carcinosarcoma cell line:JHUCS-1	10642-109A3	1936.71	18.37	5.32	4.79	6.39	2.40	4.26	1.33
caudate nucleus - adult, donor10196	10177-103C6	2806.92	14.97	9.21	6.91	4.61	0.00	2.30	1.15
caudate nucleus, adult, donor10252	10164-103B2	2249.70	11.55	3.35	5.52	3.68	2.01	1.00	2.51
caudate nucleus, adult, donor10258	10379-105H1	3379.02	12.99	3.82	9.93	3.82	2.29	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	2329.24	41.75	4.76	9.89	6.96	4.76	1.46	0.73
cerebellum - adult, donor10196	10173-103C2	1823.71	43.70	0.00	2.91	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	1284.05	21.35	2.56	0.85	2.78	1.49	1.49	0.43
cerebellum, adult, pool1	10083-102B2	1631.24	35.53	5.86	2.41	4.83	5.86	5.86	4.14
cerebellum, newborn, donor10223	10357-105E6	1381.60	29.89	4.15	3.32	0.83	1.66	0.83	1.66
cerebral meninges, adult	10188-103D8	2399.61	14.62	4.79	6.56	4.54	4.79	1.76	3.78
cerebrospinal fluid, donor2	10294-104G6	1137.26	13.16	8.77	8.77	1.46	2.19	6.58	0.00
cervical cancer cell line:D98-AH2	10552-107I3	1730.28	3.45	2.16	3.16	1.01	1.44	0.29	1.01
cervical cancer cell line:ME-180	10553-107I4	4276.81	8.78	8.12	10.27	4.31	4.47	2.82	3.15
cervix, adult, pool1	10013-101C4	6146.33	20.68	11.34	16.59	26.04	14.17	2.41	3.04
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	2899.64	24.94	6.69	6.55	2.23	3.76	1.67	2.51
chondrosarcoma cell line:SW 1353	10700-109G7	2982.18	35.27	9.14	16.98	0.00	2.61	3.92	2.61
choriocarcinoma cell line:BeWo	10423-106C9	3468.29	17.03	6.21	13.17	12.55	8.95	4.47	2.11
choriocarcinoma cell line:SCH	10785-110H2	2137.61	6.78	5.91	8.87	2.46	3.45	2.09	2.34
choriocarcinoma cell line:T3M-3	10618-108G6	2948.36	14.71	13.28	25.62	4.03	2.37	2.85	5.93
chorionic membrane cells, donor1	12238-129G6	4588.06	13.11	12.25	9.97	11.40	13.11	3.99	3.70
chorionic membrane cells, donor2	12239-129G7	7242.67	24.16	20.48	22.97	34.60	16.70	5.67	9.64
chorionic membrane cells, donor3	12240-129G8	6074.00	22.53	28.02	8.24	25.83	17.58	25.83	7.14
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7929.97	46.45	20.20	12.12	9.09	7.07	8.08	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	3936.29	19.59	18.25	15.37	4.03	6.53	4.42	6.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	4056.67	14.78	11.62	17.53	2.75	4.43	4.01	6.12
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	2481.47	9.76	3.08	2.57	1.28	0.51	1.03	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2520.37	12.34	3.63	2.18	2.66	1.45	0.97	1.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	3098.33	13.03	3.05	2.85	1.83	1.22	1.43	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	1704.60	10.31	7.36	9.42	0.88	2.36	2.06	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	5444.21	8.86	7.04	3.91	3.65	2.09	1.82	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	2979.33	27.20	9.60	9.60	5.49	6.40	3.89	4.11
clear cell carcinoma cell line:TEN	10636-108I6	3455.55	17.00	8.15	6.77	3.47	4.16	2.08	2.95
colon carcinoma cell line:CACO-2	10513-107D9	4197.34	10.62	9.70	10.43	2.38	2.20	2.20	3.29
colon carcinoma cell line:COLO-320	10420-106C6	1765.86	3.80	1.52	0.38	0.38	0.76	0.00	0.00
colon, adult, donor1	10082-102B1	6198.87	9.52	16.66	17.85	10.71	9.52	9.52	5.95
colon, adult, pool1	10014-101C5	5476.60	38.66	19.27	21.27	23.03	11.63	4.23	4.70
colon, fetal, donor1	10070-101I7	4197.38	21.01	11.12	32.75	24.10	10.51	14.83	3.09
common myeloid progenitor CMP, donor1	12130-128D6	1553.81	4.58	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	1176.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	3481.90	35.69	5.10	4.25	0.85	2.55	2.97	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	6855.01	58.56	14.19	11.02	6.34	7.09	6.64	5.28
cord blood derived cell line:COBL-a untreated	10449-106F8	7757.73	60.21	14.38	10.72	2.82	6.20	4.65	6.06
corpus callosum, adult, pool1	10042-101F6	5577.32	21.56	3.87	3.10	2.21	3.76	1.99	2.10
cruciate ligament, donor2	10295-104G7	2554.60	12.97	4.05	4.86	5.67	4.86	7.29	1.62
diaphragm, fetal, donor1	10069-101I6	1725.51	12.84	10.43	9.63	3.21	3.21	3.21	2.41
diencephalon, adult	10193-103E4	2509.08	17.28	4.80	10.32	5.52	2.88	4.56	2.88
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	6018.34	12.86	14.01	13.55	15.38	9.64	6.66	9.87
ductal cell carcinoma cell line:KLM-1	10438-106E6	3610.93	11.03	12.57	11.03	1.54	0.51	1.80	3.33
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	4106.48	19.74	10.59	18.29	4.09	4.09	2.17	4.33
ductus deferens, adult	10196-103E7	3001.50	7.48	4.98	3.99	5.98	5.98	3.99	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	3839.66	12.96	18.72	10.08	8.64	10.08	10.08	7.20
duodenum, fetal, donor1, tech_rep2	10071-101I8	4169.66	18.39	21.33	3.68	2.21	4.41	5.15	3.68
dura mater, adult, donor1	10041-101F5	9925.25	21.06	7.60	10.16	18.66	4.21	2.56	2.81
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	1182.98	63.73	2.22	2.44	4.89	2.44	1.33	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	2510.50	90.27	5.30	5.16	2.72	2.58	1.72	2.29
embryonic pancreas cell line:1B2C6	10604-108F1	1132.10	16.65	5.55	11.10	0.62	0.62	3.08	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	1774.49	22.10	8.17	6.36	1.51	2.42	2.72	2.42
embryonic pancreas cell line:1C3IKEI	10606-108F3	1699.67	19.76	1.85	5.25	1.23	0.31	1.23	1.54
embryonic pancreas cell line:2C6	10603-108E9	1564.34	9.19	7.88	10.51	1.31	0.00	2.63	5.25
endometrial carcinoma cell line:OMC-2	10497-107C2	1984.69	11.73	5.70	13.07	1.68	2.35	5.03	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	4194.51	30.45	12.51	17.76	2.54	6.34	3.62	4.89
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	4413.03	14.31	12.70	11.10	9.49	4.82	3.86	6.59
epidermoid carcinoma cell line:A431	10426-106D3	2924.58	16.78	11.23	13.23	3.22	2.89	3.67	4.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	5764.45	16.50	7.37	6.16	3.52	2.20	2.31	3.74
epididymis, adult	10197-103E8	3495.91	12.35	7.74	5.23	16.33	23.44	8.16	5.23
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	3621.47	26.26	13.48	21.64	2.84	5.50	6.56	7.27
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	2934.76	14.16	6.29	7.86	4.72	1.97	1.18	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	2611.69	7.86	5.77	3.93	3.41	5.64	3.01	1.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	2118.89	4.63	2.66	2.36	4.33	2.66	1.57	1.48
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	2848.35	10.19	8.40	5.71	4.59	3.14	2.13	3.70
esophagus, adult, pool1	10015-101C6	7865.45	18.90	20.70	16.78	31.96	15.82	3.93	5.73
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	3259.89	19.41	3.13	1.88	3.76	2.13	1.13	2.13
eye - muscle inferior rectus, donor1	10272-104E2	1173.48	7.24	2.41	2.41	0.00	0.00	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	917.43	2.10	4.21	2.10	0.00	0.00	8.42	0.00
eye - muscle medial, donor2	10299-104H2	631.00	0.00	1.49	5.95	0.00	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	1345.99	3.44	5.73	9.17	0.00	3.44	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	2130.71	13.12	2.91	10.20	5.83	2.91	10.20	1.46
eye, fetal, donor1	10054-101G9	2048.37	14.75	2.03	4.32	3.56	4.32	2.80	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	3261.13	28.98	10.00	11.41	5.13	4.87	3.59	3.72
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	3307.01	29.91	13.77	17.09	3.56	4.75	5.94	4.04
frontal lobe, adult, pool1	10040-101F4	3286.37	21.30	3.19	0.94	2.06	1.13	0.56	0.94
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	2936.14	17.41	6.31	18.92	3.90	8.71	5.10	3.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	4304.00	21.03	8.78	8.60	3.11	2.74	1.28	4.02
gall bladder, adult	10198-103E9	4910.73	18.59	7.73	8.21	18.83	9.42	2.90	2.41
gamma delta positive T cells, donor1	11937-126A2	8056.57	39.19	18.25	12.88	2.68	10.20	5.91	3.22
gamma delta positive T cells, donor2	11938-126A3	7563.58	39.96	15.69	14.57	4.86	14.94	6.72	3.36
gastric adenocarcinoma cell line:MKN1	10614-108G2	2541.99	8.87	8.03	5.91	7.82	3.38	3.59	5.07
gastric adenocarcinoma cell line:MKN45	10612-108F9	1538.04	4.06	3.48	3.48	2.13	2.32	0.77	0.97
gastric cancer cell line:AZ521	10549-107H9	1864.50	40.50	4.59	3.93	1.31	1.48	0.66	1.64
gastric cancer cell line:GSS	10560-108A2	2959.84	57.66	1.83	6.41	2.75	0.92	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	1498.22	30.38	2.97	2.06	3.20	1.60	0.91	1.60
giant cell carcinoma cell line:LU65	10487-107B1	2668.18	15.15	7.46	8.26	1.49	2.98	1.49	1.95
giant cell carcinoma cell line:Lu99B	10433-106E1	4588.42	23.09	7.28	6.02	5.74	3.22	2.66	3.08
glassy cell carcinoma cell line:HOKUG	10688-109F4	2280.68	14.47	12.47	11.72	2.00	2.99	5.49	4.99
glioblastoma cell line:A172, tech_rep1	10444-106F3	5606.10	42.64	19.53	21.64	2.43	4.64	6.54	8.34
glioblastoma cell line:A172, tech_rep2	10444-106F3	5350.57	43.68	17.70	41.85	2.11	4.49	10.25	10.81
glioblastoma cell line:T98G	10485-107A8	5604.54	38.52	15.45	20.53	2.76	4.75	3.64	7.62
glioma cell line:GI-1	10413-106B8	4991.80	14.94	3.51	8.20	9.37	3.81	4.98	1.76
globus pallidus - adult, donor10196	10175-103C4	2532.24	10.20	0.73	12.39	2.92	4.37	1.46	0.73
globus pallidus, adult, donor10252	10161-103A8	3844.73	14.16	9.28	10.50	6.83	3.91	3.91	2.69
globus pallidus, adult, donor10258	10367-105F7	2271.52	20.54	19.17	6.85	5.48	5.48	4.11	0.00
globus pallidus, newborn, donor10223	10364-105F4	2557.47	30.38	8.53	9.06	4.80	8.53	1.60	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	3726.99	12.24	4.89	7.34	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	3901.43	10.93	43.71	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	3872.90	20.91	10.45	5.23	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	4182.98	21.76	17.60	13.76	6.40	3.20	3.52	5.76
hIPS +CCl2, biol_rep1	14383-156B9	4076.02	26.63	6.89	4.59	2.30	2.30	2.75	0.46
hIPS +CCl2, biol_rep2	14384-156C1	4227.85	16.00	7.77	6.86	0.00	1.83	1.37	0.91
hIPS +CCl2, biol_rep3	14385-156C2	3945.07	21.26	7.09	11.59	0.00	5.15	0.00	0.64
hIPS, biol_rep1	14380-156B6	1812.42	25.87	11.50	21.56	1.44	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	3323.71	16.46	9.60	9.60	1.37	4.12	2.06	2.06
hIPS, biol_rep3	14382-156B8	2416.59	19.86	0.00	2.21	0.00	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	8084.41	64.65	27.30	19.25	10.63	13.51	8.91	8.62
heart - mitral valve, adult	10205-103F7	1932.23	8.07	6.58	2.69	2.99	3.29	2.09	3.29
heart - pulmonic valve, adult	10206-103F8	2479.31	7.32	4.45	4.45	2.88	2.35	7.32	0.52
heart - tricuspid valve, adult	10207-103F9	3137.39	14.15	5.83	7.49	9.99	8.33	11.66	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	2279.92	8.57	3.67	5.10	5.31	3.88	2.65	2.45
heart, adult, diseased, donor1	10051-101G6	1414.62	5.54	2.98	2.13	2.98	1.28	1.70	2.13
heart, adult, pool1	10016-101C7	2242.05	8.51	5.06	8.28	3.22	4.83	2.53	1.84
heart, fetal, pool1	10046-101G1	2458.98	7.70	2.26	0.62	1.23	1.13	0.51	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	8049.39	35.17	27.77	55.53	10.49	11.11	8.95	11.11
hepatoblastoma cell line:HuH-6	10633-108I3	1372.31	7.14	2.38	14.27	0.00	1.19	7.14	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	2738.31	8.62	5.64	5.19	4.09	2.54	2.10	1.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	2789.42	9.35	5.34	5.34	4.98	2.67	2.06	3.28
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	2919.53	9.60	5.46	3.23	4.45	3.13	1.62	2.32
hepatoma cell line:Li-7	10484-107A7	2084.96	5.23	5.00	5.12	1.67	2.00	1.00	1.45
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	7638.83	20.40	11.46	15.68	4.02	8.14	4.72	4.42
hippocampus - adult, donor10196	10169-103B7	2276.86	19.87	1.89	8.52	4.73	2.84	1.89	1.89
hippocampus, adult, donor10252	10153-102I9	1940.17	12.65	5.71	7.96	3.27	5.71	3.88	2.04
hippocampus, adult, donor10258	10374-105G5	2136.71	17.93	1.99	7.47	1.00	1.00	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	2443.02	41.24	4.93	14.10	8.11	7.05	0.70	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	4782.65	48.22	21.36	57.98	15.87	72.63	17.09	8.54
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5052.21	34.56	22.19	14.53	7.66	15.51	11.58	5.30
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	4764.09	40.12	13.71	31.99	9.65	26.91	7.87	8.12
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	4412.24	20.30	12.97	27.07	12.97	52.44	14.10	3.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	4914.54	35.12	21.95	31.76	30.47	111.55	50.09	12.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	5472.83	33.41	18.98	25.05	21.26	38.34	14.43	10.25
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	3022.30	24.23	17.23	29.49	14.31	61.89	9.63	4.96
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	3904.21	25.85	23.27	27.14	17.45	62.04	18.31	6.68
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	3775.77	23.77	10.84	32.11	10.01	38.79	5.84	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	4856.62	24.63	14.21	26.05	7.10	17.05	6.16	3.08
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	5352.20	36.16	19.93	38.57	15.43	42.27	22.18	10.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	4274.80	21.55	5.39	22.89	1.35	13.47	4.71	4.71
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	4771.68	37.24	21.59	19.72	15.02	18.00	15.80	6.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	4485.51	41.76	28.00	29.97	21.13	36.85	31.93	14.74
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	4131.61	55.86	23.56	45.38	6.11	37.53	13.96	9.60
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	5854.08	31.50	21.38	25.96	24.63	42.19	28.45	8.78
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	5261.66	25.29	13.52	23.55	18.75	27.04	17.01	5.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	3599.78	21.99	17.99	55.97	22.99	87.96	17.99	7.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	2933.26	33.91	21.48	21.85	12.43	34.48	11.30	8.10
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	2993.86	25.01	18.19	27.28	15.46	28.65	11.37	6.37
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	2453.89	25.06	11.28	29.76	9.71	41.03	10.34	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	4544.69	31.68	20.74	25.31	11.10	45.89	20.09	7.84
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	4649.88	23.52	22.64	25.84	19.74	33.39	14.23	6.97
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	3739.83	28.10	15.25	28.40	12.55	56.20	12.55	6.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	4869.87	43.23	29.19	19.40	8.50	22.54	21.80	7.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	4937.70	34.80	18.83	20.83	8.84	20.54	19.68	8.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	5159.02	53.49	14.70	40.83	16.74	61.66	17.15	8.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	4861.88	42.95	19.01	25.35	21.83	60.91	20.77	10.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	4720.38	38.64	27.56	23.76	19.00	30.09	17.10	5.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	5109.14	45.39	22.09	27.24	22.09	41.46	10.89	6.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	2936.22	19.13	16.03	17.58	12.41	19.65	3.62	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	2790.16	17.27	10.63	25.90	6.64	12.62	7.97	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	2665.12	17.19	6.93	16.42	6.67	13.34	2.82	3.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	4904.10	31.70	13.55	38.35	19.94	28.63	13.55	8.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	4080.68	20.45	17.42	27.26	7.57	13.63	7.57	6.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	4830.49	41.00	15.12	55.45	15.12	47.38	11.43	7.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	4747.53	36.71	17.63	21.49	11.11	24.39	19.08	5.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	4220.84	45.01	22.73	39.22	11.14	51.25	8.47	5.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	4507.84	47.81	27.81	35.12	9.76	46.34	15.12	5.37
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	5142.32	28.73	20.48	18.03	15.28	33.31	14.36	5.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	4060.05	45.55	39.04	61.81	3.25	162.66	26.03	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	4845.66	36.07	20.52	40.37	24.82	73.14	20.52	4.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	3583.16	23.53	12.04	14.78	2.19	9.85	10.95	5.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	2995.32	23.52	8.69	27.14	9.77	34.74	7.24	4.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	2776.16	21.35	8.54	21.71	14.23	30.25	6.41	3.91
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	3899.98	22.67	22.67	13.13	3.58	14.32	14.32	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	5825.46	31.15	10.29	21.40	18.28	34.80	7.45	5.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	4293.89	29.90	11.85	32.33	9.43	46.07	12.93	5.12
immature langerhans cells, donor1	11904-125F5	5438.36	26.88	10.90	14.29	3.39	2.66	1.45	3.15
immature langerhans cells, donor2	11905-125F6	6000.40	34.85	14.26	7.13	3.17	8.71	6.34	5.54
insula, adult, pool1	10039-101F3	3824.42	25.74	3.69	2.18	1.61	1.14	0.47	1.14
keratoacanthoma cell line:HKA-1	10791-110H8	1828.63	10.40	4.88	3.90	6.83	5.20	1.30	2.60
kidney, adult, pool1	10017-101C8	3952.63	13.22	6.21	6.11	7.91	4.41	1.90	4.11
kidney, fetal, pool1	10045-101F9	3851.63	10.96	3.82	1.91	3.75	1.20	0.50	0.99
large cell lung carcinoma cell line:IA-LM	10509-107D5	1772.28	4.97	2.84	7.24	1.85	0.85	1.85	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	1583.70	11.34	3.73	2.07	3.18	2.35	0.55	1.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	2238.33	8.44	8.26	10.46	0.73	2.02	2.94	4.04
left atrium, adult, donor1	10079-102A7	1957.10	5.99	3.81	6.54	8.17	9.26	7.63	4.90
left ventricle, adult, donor1	10078-102A6	1677.76	4.55	5.06	8.60	9.10	5.56	2.53	2.53
leiomyoblastoma cell line:G-402	10721-110A1	4935.38	50.62	24.08	32.83	4.65	4.92	4.10	9.85
leiomyoma cell line:10964C	10569-108B2	3756.31	61.07	9.70	5.75	13.29	7.18	3.95	3.59
leiomyoma cell line:15242A	10570-108B3	4402.74	50.00	12.50	4.89	8.70	3.80	3.26	2.17
leiomyoma cell line:15425	10571-108B4	4778.86	55.12	15.30	9.96	10.20	8.01	4.86	8.50
leiomyosarcoma cell line:Hs 5.T	10722-110A2	5701.73	19.05	6.35	6.35	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	2098.42	10.46	1.05	3.14	4.18	1.05	2.09	5.23
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	4152.93	26.09	6.85	11.45	4.13	2.60	2.83	3.31
liposarcoma cell line:KMLS-1	10782-110G8	3684.37	18.75	7.65	8.59	6.87	4.53	4.69	5.00
liposarcoma cell line:SW 872	10726-110A6	3408.57	28.63	10.60	11.94	4.63	3.66	0.85	4.75
liver, adult, pool1	10018-101C9	3345.92	11.83	7.78	7.13	16.04	13.61	1.62	1.94
liver, fetal, pool1	10086-102B5	2332.03	8.47	6.58	5.64	7.53	7.53	2.82	2.82
locus coeruleus - adult, donor10196	10182-103D2	2395.31	14.00	3.94	7.00	2.48	2.77	2.77	0.58
locus coeruleus, adult, donor10252	10165-103B3	1904.01	17.53	3.32	3.69	3.32	4.61	2.21	1.11
locus coeruleus, adult, donor10258	10375-105G6	2507.92	38.65	18.06	8.46	14.95	14.67	4.51	5.92
locus coeruleus, newborn, donor10223	10362-105F2	3089.44	33.23	8.41	29.86	9.25	20.19	9.67	5.89
lung adenocarcinoma cell line:A549	10499-107C4	2624.93	8.72	5.81	11.90	2.35	2.35	3.32	2.91
lung adenocarcinoma cell line:PC-14	10408-106B3	4033.72	17.24	13.10	17.24	0.69	1.38	0.69	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	2028.65	16.87	11.60	6.20	3.95	1.45	2.24	3.56
lung, adult, pool1	10019-101D1	5370.43	27.52	12.52	15.59	30.12	13.35	3.19	7.09
lung, fetal, donor1	10068-101I5	4742.90	11.42	8.56	1.43	3.14	1.71	2.00	1.14
lung, right lower lobe, adult, donor1	10075-102A3	4666.48	28.41	14.66	21.54	49.95	36.20	32.53	8.25
lymph node, adult, donor1	10077-102A5	6715.59	25.56	16.09	13.73	35.03	25.56	17.51	5.68
lymphangiectasia cell line:DS-1	10727-110A7	3354.08	20.82	14.25	13.81	4.60	3.95	3.95	3.29
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	7238.29	21.73	18.87	16.60	6.34	6.79	3.62	5.89
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	2692.05	16.14	16.14	16.14	1.70	1.70	3.40	1.70
mature adipocyte, donor1	12231-129F8	2689.69	11.99	2.22	5.33	2.66	1.78	0.44	0.89
mature adipocyte, donor2	12232-129F9	2453.19	18.26	3.94	6.43	1.25	2.28	0.62	1.25
mature adipocyte, donor3	12233-129G1	1898.16	10.67	3.32	2.13	2.61	0.71	0.47	0.95
mature adipocyte, donor4	12234-129G2	1706.70	11.84	4.74	2.11	1.05	2.63	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	1801.95	9.77	3.57	5.72	4.77	2.86	1.43	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	2163.56	18.05	4.51	4.51	3.38	3.38	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	1733.32	10.67	3.86	3.68	3.13	3.49	2.02	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	1849.89	14.61	5.08	6.04	1.59	4.13	2.22	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	1925.17	29.00	2.13	10.24	5.54	1.71	1.28	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	2535.65	20.42	5.40	4.73	7.76	10.97	4.73	3.71
medial temporal gyrus, adult, donor10252	10156-103A3	1916.18	8.91	1.70	5.94	2.97	3.18	1.91	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1096.04	17.34	11.56	9.63	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1306.18	0.00	28.71	0.00	14.35	28.71	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	2142.11	46.66	3.95	7.90	5.38	5.03	1.08	0.72
medulla oblongata - adult, donor10196	10174-103C3	1942.39	12.98	1.95	10.38	1.95	1.30	3.24	0.65
medulla oblongata, adult, donor10252	10155-103A2	2359.37	12.07	3.72	2.63	5.11	4.95	3.25	1.08
medulla oblongata, adult, pool1	10038-101F2	4566.56	25.14	4.24	1.55	1.80	1.31	0.65	0.98
medulla oblongata, newborn, donor10223	10361-105F1	3067.34	19.79	7.64	11.80	4.17	6.25	2.78	3.82
medulloblastoma cell line:D283 Med	10838-111E1	2292.50	4.21	2.88	1.77	2.44	0.89	1.11	0.66
medulloblastoma cell line:ONS-76	10759-110E3	4137.71	25.92	10.39	18.46	3.18	3.55	1.47	3.91
melanoma cell line:COLO 679	10514-107E1	2398.12	35.36	4.02	6.18	7.62	4.89	2.30	2.73
melanoma cell line:G-361	10465-106H6	2560.16	39.36	5.16	13.30	6.79	6.24	5.16	0.81
meningioma cell line:HKBMM	10691-109F7	2248.64	7.96	8.14	4.16	7.06	2.71	2.17	3.26
merkel cell carcinoma cell line:MKL-1	10843-111E6	3090.22	27.32	21.15	10.57	3.52	4.41	8.81	16.74
merkel cell carcinoma cell line:MS-1	10844-111E7	2561.90	16.59	7.52	1.56	2.59	3.89	5.70	3.63
mesenchymal precursor cell - adipose, donor1	11747-123G1	4528.30	22.86	7.36	5.22	13.04	9.05	7.67	4.45
mesenchymal precursor cell - adipose, donor2	11748-123G2	4410.73	9.63	6.36	4.00	10.00	4.36	4.18	3.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	3159.60	14.49	4.97	2.48	2.48	4.14	1.66	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4004.38	6.46	3.93	3.51	12.78	5.90	2.53	2.95
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	3335.09	9.82	5.97	2.89	9.44	10.21	3.27	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	2843.64	14.58	4.16	6.25	1.39	2.08	1.39	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	1518.28	6.69	2.40	1.03	6.69	3.26	3.09	1.20
mesenchymal precursor cell - cardiac, donor2	11753-123G7	2944.52	9.55	4.03	1.61	11.04	2.76	5.29	1.61
mesenchymal precursor cell - cardiac, donor3	11754-123G8	4807.83	14.72	6.37	4.24	10.48	9.02	5.31	2.79
mesenchymal precursor cell - cardiac, donor4	11755-123G9	4032.44	14.99	6.35	3.51	9.99	5.13	4.73	2.97
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	4782.44	14.80	6.69	5.69	11.52	4.27	4.55	3.98
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	1213.67	6.26	2.96	0.33	0.99	1.98	0.66	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	6133.61	16.05	10.93	5.67	12.32	7.47	6.64	4.29
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	5574.16	20.25	10.12	9.43	3.49	6.28	4.54	4.54
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	4602.69	13.27	7.96	4.49	10.41	9.80	3.27	2.45
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	4414.46	25.52	6.83	9.35	6.47	3.24	3.95	5.03
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	5623.94	12.52	7.45	5.07	12.83	7.66	6.00	1.86
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	4301.29	29.64	8.21	11.63	10.03	5.02	2.74	5.93
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	4346.61	18.88	8.39	3.78	5.45	3.78	5.45	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	5414.73	11.36	6.43	4.18	14.94	10.61	7.92	3.59
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	4352.90	13.57	5.51	4.20	10.42	5.08	4.20	2.54
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	3453.71	9.20	5.15	5.52	1.84	2.58	2.58	3.31
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	5720.00	24.04	13.16	13.45	4.01	4.86	4.86	3.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	6753.91	50.94	21.05	21.89	12.21	8.84	6.74	10.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	5625.72	33.79	17.35	13.24	10.96	6.39	6.85	7.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	5169.40	35.30	11.00	8.19	9.21	8.44	6.65	4.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	5776.97	35.08	15.97	9.68	5.76	6.54	5.50	4.19
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	5481.17	40.36	19.41	12.94	6.47	7.39	5.85	3.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	5137.33	33.19	7.77	5.41	8.00	9.88	5.18	3.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5649.85	31.81	13.54	7.11	3.38	8.46	4.74	2.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	5562.91	33.01	11.40	5.50	5.89	6.29	4.32	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5159.80	31.51	18.07	4.63	4.17	6.95	5.56	3.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	4878.66	48.30	48.30	0.00	0.00	96.61	0.00	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	6768.00	47.01	10.96	7.50	10.38	10.96	4.33	3.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	5784.77	33.24	13.61	7.14	3.79	9.37	4.91	2.90
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	5458.39	34.61	17.79	10.82	8.41	13.70	6.25	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	5626.09	28.60	22.00	7.33	6.60	5.87	3.67	5.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	4701.21	38.60	11.75	6.38	2.69	7.72	3.69	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4754.93	35.21	11.05	2.87	3.68	6.55	3.28	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	5198.08	32.65	14.18	4.30	3.01	8.59	7.30	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5900.86	41.02	41.02	10.94	2.73	10.94	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	6037.88	46.48	67.14	30.99	0.00	0.00	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	5717.86	36.70	19.81	26.63	10.39	6.50	3.57	5.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	6076.03	48.01	26.19	24.73	2.91	14.55	10.18	5.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	6276.48	52.77	15.99	25.05	12.26	8.53	4.26	7.46
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5569.84	51.52	17.17	28.62	4.91	12.27	4.09	9.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5396.60	40.82	17.88	30.71	12.44	9.72	6.61	7.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	5442.00	44.07	20.99	25.18	6.30	10.49	4.20	10.49
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5073.64	43.71	23.84	21.86	8.94	10.93	4.97	4.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	5601.49	52.44	19.07	9.53	0.00	9.53	4.77	19.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	4901.45	40.91	20.16	29.06	6.52	10.67	8.89	3.56
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6148.34	35.34	30.46	26.81	3.66	19.50	7.31	8.53
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	6005.65	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5720.71	34.20	23.44	19.00	8.23	8.87	4.43	6.97
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	1940.43	18.62	6.55	8.97	3.10	3.45	2.41	3.10
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2114.82	19.34	10.75	4.30	2.15	6.45	8.60	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	2227.42	7.98	19.96	19.96	0.00	15.97	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	933.29	10.33	3.44	3.44	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	903.36	4.48	1.22	2.04	0.81	4.07	2.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	885.01	8.74	3.18	2.38	0.79	4.77	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	815.90	3.54	2.95	1.77	0.59	1.18	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	724.40	3.43	0.94	2.81	0.94	2.18	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	890.22	5.35	5.35	2.67	0.00	4.01	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1824.86	10.64	10.64	4.73	0.00	2.37	5.91	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	1902.89	15.41	12.84	7.70	2.57	10.27	10.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	2001.86	11.01	5.51	5.51	0.69	6.20	2.07	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	1516.59	5.94	3.96	3.96	2.97	4.45	1.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	1436.65	6.73	5.61	7.85	0.00	7.85	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1478.21	10.18	7.63	3.82	1.91	3.18	0.00	3.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1779.57	7.66	6.45	3.63	2.82	2.82	2.01	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	1894.93	4.36	15.26	6.54	8.72	0.00	4.36	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1822.03	13.94	12.67	2.53	5.07	5.07	2.53	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	535.88	1.82	1.21	0.61	1.82	0.61	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	655.25	13.56	9.04	0.00	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	629.29	4.12	2.47	1.65	1.65	1.65	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	1808.06	11.31	6.75	3.17	1.19	2.78	4.56	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	1930.41	10.38	3.57	6.81	4.22	3.89	2.60	2.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	2092.26	21.39	11.20	6.11	4.07	10.19	3.06	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	4138.60	13.15	3.09	10.06	0.77	3.09	3.09	3.09
mesothelioma cell line:ACC-MESO-1	10493-107B7	3899.16	51.26	16.30	47.72	4.02	5.91	8.03	10.16
mesothelioma cell line:ACC-MESO-4	10494-107B8	3672.49	31.97	12.97	23.86	1.16	6.02	4.87	5.79
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	3722.30	12.82	8.55	12.82	4.27	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	3122.37	20.04	5.14	4.32	3.08	7.60	1.13	1.64
mesothelioma cell line:Mero-25	10850-111F4	2297.23	12.94	4.54	2.95	1.59	3.86	0.45	2.27
mesothelioma cell line:Mero-41	10851-111F5	8944.86	30.80	17.85	13.45	7.58	11.73	4.65	8.31
mesothelioma cell line:Mero-48a	10852-111F6	7438.97	30.56	22.14	9.74	8.86	7.75	5.98	6.42
mesothelioma cell line:Mero-82	10853-111F7	3353.92	21.29	11.04	7.10	3.42	6.04	4.73	5.52
mesothelioma cell line:Mero-83	10854-111F8	3505.35	22.47	7.83	8.68	4.60	6.81	3.40	3.06
mesothelioma cell line:Mero-84	10855-111F9	5069.63	37.16	14.91	8.34	4.04	5.06	1.52	10.36
mesothelioma cell line:Mero-95	10856-111G1	5082.48	34.58	10.56	9.52	9.94	6.21	2.69	3.52
mesothelioma cell line:NCI-H2052	10847-111F1	3202.80	17.06	6.96	4.64	2.82	2.65	2.82	2.82
mesothelioma cell line:NCI-H226	10846-111E9	5613.82	44.34	11.40	8.87	6.88	5.79	3.62	3.80
mesothelioma cell line:NCI-H2452	10848-111F2	3394.24	18.62	7.86	3.59	2.73	4.27	2.05	3.59
mesothelioma cell line:NCI-H28	10845-111E8	2178.99	24.43	8.40	4.33	2.54	1.78	1.53	1.27
mesothelioma cell line:No36	10857-111G2	3933.68	11.42	11.42	6.52	6.52	5.87	2.28	2.28
mesothelioma cell line:ONE58	10858-111G3	3763.25	15.72	21.95	7.86	4.34	8.67	3.25	3.52
migratory langerhans cells, donor1	11901-125F2	15610.02	42.99	37.62	41.26	10.94	17.46	5.95	18.62
migratory langerhans cells, donor2	11902-125F3	14247.82	33.95	32.36	28.94	10.26	10.50	4.03	13.07
migratory langerhans cells, donor3	11903-125F4	16047.89	40.38	43.25	45.23	9.33	9.33	4.13	11.67
mixed mullerian tumor cell line:HTMMT	10689-109F5	2794.99	25.14	23.51	11.10	3.59	10.12	8.81	7.51
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	3022.21	19.71	11.02	14.41	6.57	8.69	5.51	3.60
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	3519.17	12.21	8.29	22.81	2.53	4.38	2.07	4.61
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11104.69	76.31	33.68	30.83	26.26	21.69	12.18	11.42
myelodysplastic syndrome cell line:SKM-1	10772-110F7	5505.33	14.97	14.60	10.90	2.22	2.77	3.14	4.25
myeloma cell line:PCM6	10474-106I6	3857.28	9.88	9.49	15.02	3.76	6.33	5.34	4.15
myxofibrosarcoma cell line:MFH-ino	10600-108E6	3557.12	9.64	6.09	10.15	2.54	1.52	6.09	6.09
myxofibrosarcoma cell line:NMFH-1	10684-109E9	2577.47	11.18	5.88	4.90	3.33	1.96	1.77	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	3351.65	7.91	7.80	5.79	3.34	4.12	2.34	2.90
nasal epithelial cells, donor1, tech_rep2	12226-129F3	3041.78	6.03	6.40	5.37	2.65	4.12	1.03	1.76
nasal epithelial cells, donor2	12227-129F4	3281.58	11.04	3.86	2.76	1.10	1.10	1.66	2.21
neuroblastoma cell line:CHP-134	10508-107D4	3414.10	8.51	8.74	11.73	1.38	4.14	2.07	2.30
neuroblastoma cell line:NB-1	10539-107G8	4624.19	36.29	8.04	10.85	2.62	3.74	2.43	4.49
neuroblastoma cell line:NBsusSR	10607-108F4	1382.80	5.48	3.80	2.95	1.48	2.11	0.84	1.05
neuroblastoma cell line:NH-12	10555-107I6	2066.63	16.03	3.54	4.66	2.05	0.56	0.75	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	2264.56	5.46	4.03	6.17	4.03	3.80	2.85	2.37
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1733.00	6.49	4.91	8.55	5.86	5.86	6.65	2.69
neuroectodermal tumor cell line:TASK1	10774-110F9	2239.82	9.26	7.65	13.69	3.82	3.02	2.01	2.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	1768.07	7.63	5.09	12.72	0.64	1.27	1.27	3.81
neurofibroma cell line:Hs 53.T	10729-110A9	6929.38	29.01	36.73	51.90	5.06	8.25	9.32	10.65
neutrophil PMN, donor1	12133-128D9	8627.39	44.62	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	10544.85	0.00	13.28	13.28	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	15636.02	37.88	28.41	0.00	0.00	18.94	9.47	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	2813.49	6.60	2.88	2.88	1.52	2.20	2.03	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	2301.46	31.22	1.60	2.40	1.60	1.60	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	4335.88	25.33	19.24	17.31	10.58	12.50	7.05	6.09
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	7277.26	39.15	21.02	13.93	6.57	11.82	12.09	7.36
nucleus accumbens, adult, pool1	10037-101F1	3572.49	21.19	3.37	2.34	1.78	1.31	0.56	1.59
occipital cortex - adult, donor10196	10172-103C1	2561.06	24.72	4.12	0.00	4.12	0.00	4.12	4.12
occipital cortex, adult, donor10252	10163-103B1	1915.84	9.93	4.83	9.12	2.95	4.03	4.03	0.54
occipital cortex, newborn, donor10223	10355-105E4	2588.73	41.49	3.64	5.82	3.28	2.91	2.55	2.18
occipital lobe, adult, donor1	10076-102A4	3304.65	31.23	13.38	28.60	25.72	16.53	4.99	5.51
occipital lobe, fetal, donor1	10073-102A1	4169.57	25.75	16.31	20.60	20.17	19.31	5.58	10.30
occipital pole, adult, pool1	10036-101E9	3728.73	25.47	2.68	1.58	1.58	0.55	0.63	1.02
olfactory region, adult	10195-103E6	2394.07	14.71	5.92	5.92	3.44	3.06	3.25	2.29
optic nerve, donor1	10277-104E7	4222.21	34.02	16.01	6.00	6.00	6.00	4.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	2424.42	9.11	3.30	3.99	5.24	1.71	0.80	2.16
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1564.83	7.83	2.47	3.43	0.96	1.51	0.96	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	2837.53	11.51	7.45	7.11	6.26	3.56	2.54	3.89
oral squamous cell carcinoma cell line:SAS	10544-107H4	2498.11	6.35	5.31	5.31	3.00	1.85	1.50	1.85
osteoclastoma cell line:Hs 706.T	10704-109H2	4677.01	23.52	15.87	9.70	5.29	4.41	3.82	4.70
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	3783.12	12.15	11.21	22.42	0.00	4.67	3.74	5.61
osteosarcoma cell line:HS-Os-1	10558-107I9	3250.44	7.00	4.88	7.63	2.33	2.12	1.27	1.06
ovary, adult, pool1	10020-101D2	5973.88	17.21	10.22	9.87	23.15	12.14	1.83	3.23
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	4407.57	34.83	26.95	39.96	6.60	6.60	5.87	8.62
pancreas, adult, donor1	10049-101G4	1252.93	8.47	1.88	1.88	0.00	1.88	0.94	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	2682.14	10.62	8.11	12.30	6.43	4.75	8.11	3.63
papillary adenocarcinoma cell line:8505C	10437-106E5	4160.54	23.85	8.18	8.35	7.33	4.26	3.92	6.47
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	4753.87	17.39	7.95	8.78	5.96	4.80	1.66	3.81
paracentral gyrus, adult, pool1	10035-101E8	3426.68	23.80	3.29	2.75	2.47	1.56	0.92	0.92
parietal cortex, adult, donor10258	10373-105G4	2127.15	17.62	1.47	0.00	0.00	0.00	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	1850.87	15.05	0.94	4.70	5.64	2.82	5.64	0.94
parietal lobe, adult, donor10252	10157-103A4	1567.99	9.41	1.14	2.85	1.71	3.14	1.43	2.00
parietal lobe, adult, pool1	10034-101E7	3246.24	22.29	2.64	1.15	1.50	0.88	0.70	1.15
parietal lobe, fetal, donor1	10072-101I9	3230.52	17.46	19.40	24.25	7.76	15.52	7.76	6.79
parietal lobe, newborn, donor10223	10356-105E5	2458.50	54.21	3.74	11.22	3.36	3.74	0.75	3.36
parotid gland, adult	10199-103F1	1897.47	1.85	3.08	4.32	1.85	2.47	1.85	2.47
penis, adult	10200-103F2	4344.70	16.11	20.41	4.83	12.35	10.21	8.06	5.91
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2954.71	21.01	9.67	6.88	5.39	4.09	2.23	3.16
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	3735.47	13.26	11.07	15.44	5.54	4.52	2.91	4.37
pineal gland - adult, donor10196	10179-103C8	910.13	12.26	0.65	1.94	0.65	0.00	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	1198.64	9.48	1.78	0.59	0.59	0.59	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	1077.94	10.03	0.00	3.76	1.25	2.51	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	1809.10	16.19	2.02	3.04	2.02	2.02	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	2010.19	15.64	2.08	2.61	1.04	1.56	1.04	1.04
pituitary gland, adult, donor10258	10378-105G9	1282.82	19.58	1.70	2.55	0.85	3.40	0.00	0.00
placenta, adult, pool1	10021-101D3	3793.13	14.30	5.05	4.95	5.81	4.30	1.08	2.58
plasma cell leukemia cell line:ARH-77	10840-111E3	5232.45	29.00	10.99	4.37	4.77	2.91	2.52	3.31
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	4302.34	13.07	9.49	14.63	3.27	3.74	5.45	1.87
pons, adult, pool1	10033-101E6	2764.14	18.42	2.75	1.81	1.81	1.03	0.77	1.12
postcentral gyrus, adult, pool1	10032-101E5	3761.62	23.97	4.79	1.57	2.44	1.39	0.87	1.83
promyelocytes/myelocytes PMC, donor1	12132-128D8	2727.18	6.27	0.00	0.00	0.00	0.00	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	3580.22	5.51	11.02	11.02	11.02	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	3508.99	11.74	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	3801.48	35.69	9.47	11.22	3.50	5.39	2.48	4.08
prostate cancer cell line:PC-3	10439-106E7	3583.93	15.06	15.43	34.12	2.72	4.36	6.53	7.62
prostate, adult, pool1	10022-101D4	5521.22	15.60	8.16	7.71	19.68	5.26	2.36	2.09
putamen, adult, donor10196	10176-103C5	2767.37	15.11	4.25	3.30	4.01	2.83	3.07	2.60
putamen, adult, donor10252	10152-102I8	2325.42	33.33	9.80	9.80	0.00	5.88	5.88	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	1630.47	15.30	6.56	8.74	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	2659.91	13.05	4.35	3.62	2.66	1.93	1.93	0.97
putamen, newborn, donor10223	10365-105F5	2677.79	28.49	6.00	6.75	6.00	9.75	3.00	4.50
rectal cancer cell line:TT1TKB	10469-106I1	2127.90	6.40	8.44	29.38	0.87	2.91	7.56	5.53
rectum, fetal, donor1	10067-101I4	4645.91	31.99	12.52	25.04	9.74	16.69	9.74	11.13
renal cell carcinoma cell line:OS-RC-2	10411-106B6	2917.94	37.31	2.76	1.70	1.70	2.12	0.85	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	405.93	7.04	1.66	1.66	0.00	0.41	0.83	1.24
retina, adult, pool1	10030-101E3	2946.60	12.33	2.39	1.69	3.78	1.09	0.70	0.99
retinoblastoma cell line:Y79	10475-106I7	1756.26	8.05	3.12	6.50	0.52	1.56	1.56	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	2819.57	21.39	10.57	19.92	2.46	5.04	2.58	4.43
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	2460.50	11.25	9.00	22.50	1.69	1.97	4.78	5.91
sacrococcigeal teratoma cell line:HTST	10695-109G2	3915.83	19.70	14.40	25.01	0.76	1.52	6.06	9.09
salivary acinar cells, donor1	11771-123I7	1775.08	8.25	2.43	1.94	3.56	1.78	1.46	0.81
salivary acinar cells, donor2	11772-123I8	1779.88	9.23	2.89	1.79	2.75	1.79	2.07	0.83
salivary acinar cells, donor3	11773-123I9	1435.33	6.62	5.30	3.31	0.00	0.00	3.31	1.32
salivary gland, adult, pool1	10093-102C3	2141.39	1.72	2.86	1.14	0.57	2.86	1.72	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	2931.09	27.06	4.89	5.40	4.38	1.94	0.67	2.19
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	2567.80	20.34	3.88	6.47	3.17	2.70	2.47	2.23
seminal vesicle, adult	10201-103F3	3319.39	27.51	27.51	12.17	7.94	23.28	8.47	14.28
serous adenocarcinoma cell line:JHOS-2	10639-108I9	1541.12	7.77	4.62	2.43	3.64	0.97	1.46	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	1370.89	9.56	3.02	1.26	1.51	2.26	0.25	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	3455.16	25.09	10.04	6.02	0.00	3.01	0.00	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	3331.02	13.16	6.45	3.90	3.09	3.90	2.01	2.01
signet ring carcinoma cell line:Kato III	10436-106E4	2028.74	8.51	4.31	2.76	1.77	1.33	0.99	1.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	2335.74	14.84	4.77	5.42	2.32	1.03	1.42	1.81
skeletal muscle - soleus muscle, donor1	10282-104F3	612.16	6.38	2.13	1.42	0.71	0.71	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	2011.35	9.00	4.92	5.28	3.48	3.00	0.48	1.20
skeletal muscle, fetal, donor1	10066-101I3	2490.43	8.04	14.07	6.03	8.04	4.02	6.03	6.03
skin, adult, donor1	10074-102A2	3854.00	13.57	0.00	13.57	20.36	0.00	27.14	0.00
skin, fetal, donor1	10065-101I2	2336.17	13.26	13.89	34.72	6.31	11.99	4.42	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	4010.28	20.01	23.68	16.34	5.00	9.01	4.00	5.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	2514.71	15.13	5.67	4.10	4.73	3.78	2.21	2.84
small cell lung carcinoma cell line:DMS 144	10841-111E4	2914.34	29.68	5.20	3.28	5.78	1.54	0.96	2.31
small cell lung carcinoma cell line:LK-2	10541-107H1	1860.40	12.20	4.62	6.76	1.15	1.15	0.33	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2486.74	9.17	2.09	3.38	2.09	0.80	1.13	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	2162.18	10.46	5.23	5.67	2.18	1.09	1.53	2.18
small intestine, adult, pool1	10024-101D6	6928.53	26.16	16.36	21.62	32.37	14.81	4.54	5.26
small intestine, fetal, donor1	10064-101I1	3598.22	9.34	6.88	5.41	9.34	7.62	9.58	4.91
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	2316.26	24.11	7.18	7.69	3.59	5.13	3.08	5.13
smooth muscle, adult, pool1	10048-101G3	8683.83	20.68	24.55	13.96	19.38	9.56	10.34	7.75
somatostatinoma cell line:QGP-1	10781-110G7	2233.42	12.87	7.50	10.99	1.34	2.68	1.34	2.41
spinal cord - adult, donor10196	10181-103D1	3016.69	19.27	8.49	7.80	7.57	7.11	4.82	2.52
spinal cord, adult, donor10252	10159-103A6	3560.66	11.04	6.31	3.94	3.94	4.34	3.94	1.18
spinal cord, adult, donor10258	10369-105F9	2448.27	20.06	6.23	7.61	0.69	3.46	1.38	1.38
spinal cord, fetal, donor1	10056-101H2	3838.30	28.05	10.37	21.95	6.71	9.15	3.05	7.93
spinal cord, newborn, donor10223	10359-105E8	3542.36	22.04	6.89	7.35	11.94	5.51	1.38	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	9421.72	40.92	27.93	44.96	9.41	8.51	4.63	12.10
spleen, adult, pool1	10025-101D7	6686.91	22.69	10.68	12.00	23.46	16.52	3.41	4.85
spleen, fetal, pool1	10044-101F8	6887.17	19.31	6.36	4.37	8.34	3.89	1.99	2.94
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	6719.91	11.49	7.66	9.32	4.35	3.31	2.17	3.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	1958.95	6.46	11.20	20.13	0.38	2.47	5.89	3.61
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	2991.66	6.99	9.78	4.54	5.24	2.45	4.19	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	2345.59	17.20	5.86	7.43	0.78	0.39	0.78	2.35
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	2379.72	12.16	9.00	11.71	1.24	1.80	1.91	4.05
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1424.57	7.20	2.12	2.97	1.69	2.12	0.00	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	6628.25	29.61	9.73	12.69	7.62	1.69	0.00	3.38
stomach, fetal, donor1	10062-101H8	2976.44	17.09	11.75	34.18	5.34	3.20	10.68	7.48
submaxillary gland, adult	10202-103F4	1997.87	5.70	5.13	6.27	0.57	7.41	1.14	7.98
substantia nigra - adult, donor10196	10178-103C7	4450.48	108.55	54.27	325.64	0.00	108.55	162.82	108.55
substantia nigra, adult, donor10252	10158-103A5	2355.18	9.14	5.82	5.61	4.98	4.57	4.98	2.28
substantia nigra, adult, donor10258	10371-105G2	1816.07	11.90	2.07	4.66	0.52	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	2729.50	18.37	2.83	18.37	4.24	4.95	2.12	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	3085.91	13.99	11.23	16.74	3.21	5.27	3.44	4.36
temporal lobe, adult, pool1	10031-101E4	4249.89	28.82	5.26	4.49	5.34	2.71	1.10	1.19
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	4079.87	24.22	4.27	34.19	4.99	19.23	7.83	9.97
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	4376.48	25.05	13.63	6.59	2.20	4.83	3.52	7.91
tenocyte, donor1	11763-123H8	6754.75	18.50	16.06	16.06	6.98	10.47	4.19	7.68
tenocyte, donor2	11765-123I1	3208.08	11.83	7.25	7.63	4.20	4.58	1.53	1.91
tenocyte, donor3	11768-123I4	5435.81	20.39	11.49	13.34	5.56	7.78	3.34	4.82
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	6064.53	49.12	20.91	20.23	7.99	8.67	9.52	6.12
teratocarcinoma cell line:NCR-G1	10798-110I6	2934.67	17.11	10.33	9.87	8.63	6.94	5.24	3.24
teratocarcinoma cell line:PA-1	10807-111A6	5565.25	26.19	17.82	17.98	6.82	10.38	5.89	6.82
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	4289.81	23.61	10.54	19.80	26.53	8.38	7.74	4.32
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	3605.50	24.96	3.78	13.99	4.54	2.27	3.78	4.92
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	2975.77	16.03	7.74	7.31	14.72	2.29	4.58	3.05
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	4149.78	18.89	11.07	9.45	6.51	7.17	7.49	4.89
testis, adult, pool1	10026-101D8	4834.24	33.61	8.70	13.85	41.88	33.82	5.05	3.65
testis, adult, pool2	10096-102C6	2581.11	31.58	6.32	4.06	4.06	1.80	2.71	1.35
thalamus - adult, donor10196	10168-103B6	2738.99	11.04	2.21	7.73	2.21	4.42	7.73	1.10
thalamus, adult, donor10252	10154-103A1	2417.70	10.78	4.22	5.16	5.47	3.91	2.81	1.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	1068.49	44.65	6.16	24.63	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	1777.00	19.27	9.55	9.55	4.78	18.12	3.13	1.65
thalamus, newborn, donor10223	10366-105F6	1658.65	29.92	4.03	14.96	3.45	2.88	3.45	2.30
throat, adult	10209-103G2	2668.47	12.23	3.75	2.75	7.99	3.99	2.50	3.99
throat, fetal, donor1	10061-101H7	2043.66	9.45	2.74	4.88	6.40	3.96	2.44	2.44
thymic carcinoma cell line:Ty-82	10803-111A2	1985.13	4.77	2.78	4.57	1.79	3.18	1.39	1.79
thymus, adult, pool1	10027-101D9	11235.48	37.58	14.91	12.63	44.24	28.33	6.06	6.46
thymus, fetal, pool1	10043-101F7	6590.46	26.39	7.27	4.99	13.51	5.51	2.08	2.08
thyroid carcinoma cell line:KHM-5M	10776-110G2	3071.66	9.17	5.98	3.72	5.19	8.51	3.32	3.32
thyroid carcinoma cell line:TCO-1	10783-110G9	3616.59	10.20	11.45	11.73	5.59	6.43	3.21	4.19
thyroid, adult, pool1	10028-101E1	2403.37	5.69	3.55	3.64	5.69	2.99	1.31	1.68
thyroid, fetal, donor1	10060-101H6	2221.36	6.33	5.80	9.76	4.48	5.27	8.44	5.01
tongue epidermis (fungiform papillae), donor1	10288-104F9	1050.15	9.24	0.00	0.00	0.00	6.16	12.32	0.00
tongue, adult	10203-103F5	2569.05	11.16	6.74	4.42	9.54	4.19	2.79	3.95
tongue, fetal, donor1	10059-101H5	2202.19	9.06	5.91	2.76	6.31	6.70	6.31	2.76
tonsil, adult, pool1	10047-101G2	8079.16	19.53	8.62	4.71	5.71	3.61	0.70	2.40
trachea, adult, pool1	10029-101E2	4530.58	11.70	5.15	6.05	8.59	4.42	2.29	1.47
trachea, fetal, donor1	10058-101H4	2062.35	10.77	8.85	5.39	3.85	3.46	3.46	3.08
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	6407.43	46.06	22.32	25.15	8.50	10.63	7.44	8.86
transitional-cell carcinoma cell line:5637	10418-106C4	4650.33	34.75	5.78	6.48	4.05	2.23	1.01	3.65
transitional-cell carcinoma cell line:JMSU1	10492-107B6	2935.06	12.22	8.46	21.47	5.17	7.68	6.42	3.76
tridermal teratoma cell line:HGRT	10694-109G1	3445.48	22.83	5.71	41.86	0.00	3.81	34.25	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	2463.92	8.89	5.25	5.84	3.81	3.22	2.79	2.37
umbilical cord, fetal, donor1	10057-101H3	4836.51	12.52	14.61	12.52	4.17	6.26	6.26	4.17
uterus, adult, pool1	10100-102D1	6960.78	12.97	7.51	2.90	7.68	3.75	3.24	3.07
uterus, fetal, donor1	10055-101H1	4340.13	18.94	11.77	9.21	3.58	7.17	7.68	6.66
vagina, adult	10204-103F6	2522.11	9.05	3.88	0.65	7.11	1.29	2.58	0.00
vein, adult	10191-103E2	4660.81	12.06	7.45	5.70	8.99	9.21	5.26	4.16
xeroderma pigentosum b cell line:XPL 17	10563-108A5	10966.94	33.11	32.58	21.90	12.02	10.15	7.21	9.35